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ABSTRACT

Layer-by-layer (LbL) self-assembly has demonstrated broad perspectives for
encapsulating, and the controllable delivery, of drugs. The nano-scale polymer layers
have the capability o f material protection. Magnetic nanoparticles have great potential to
be applied with LbL technology to achieve both "focusing" of the encapsulated drugs to a
specific location followed by "switching" them on to release the encapsulated drugs. In
this work, Phor21-(3CG(ala), dextran, and dexamethasone were used as model drugs.
Encapsulation of these drugs with layer-by-layer self-assembly formed bio/nano robotic
capsules for controlled delivery and drug release.
Silica nanoparticles coated with polyelectrolyte layers o f sodium carboxymethyl
cellulose (CMC) or gelatin B, along with an oppositely charged peptide drug (Phor21|3CG(ala)), were prepared using LbL self-assembly and confirmed using QCM and zeta
potential measurements. The peptide drug was assembled as a component o f the
multilayer walls. The release kinetics o f the embedded peptide were determined. Up to 18
% o f the embedded Phor21-[3CG(ala) was released from the CMC multilayers over a
period of 28 hours. The release was based on physiological conditions, and an external
control mechanism using magnetic nanoparticles needed to be developed.
Magnetic permeability control experiments were setup by applying LbL selfassembly on MnCC>3 micro-cores to fabricate polyelectrolyte microcapsules embedded
with superparamagnetic gold coated cobalt (Co@Au) nanoparticles. An alternating
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magnetic field was applied to the microcapsules to check for changes in permeability.
Permeability experiments were achieved by adding fluorescein isothiocyanate (FITC)
labeled dextran to the microcapsule solution. Before an alternating magnetic field was
applied, the capsules remained impermeable to the FITC-dextran; however, after an
alternating magnetic field was applied for 30 minutes, approximately 99 % o f the
capsules were

filled with FITC-dextran,

showing that the Co@Au embedded

microcapsules were indeed “switched on” using an alternating magnetic field.
LbL assembly was then applied to encapsulate micronized dexamethasone with
biocompatible polyelectrolytes such as protamine sulfate C, chondroitin sulfate sodium
salt, and gelatin B, along with a layer o f superparamagnetic nanoparticles. The
biocompatible polymers were used to retain and protect the vulnerable drug. In vitro drug
release kinetics were investigated according to different environmental factors such as
temperature and pH. An external oscillating magnetic field was applied to “switch on”
and accelerate the drug release. The results were compared to those without applying a
magnetic field.
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CHAPTER 1

INTRODUCTION

In this research, magnetic nanoparticles incorporated in polymeric shells for the
enhanced delivery o f encapsulated drug molecules was explored. The polymeric shells,
embedded with a layer o f magnetic nanoparticles, were formed via layer-by-layer selfassembly around a core formed from the releasing agent. After formation of the core
shell capsules, a low frequency, alternating magnetic field was applied to the capsules to
allow the encapsulated drug to be released through the polymeric walls, delivering the
agent to the specified target. These capsules can be considered as bio/nano robots
activated by external magnetic fields for the controlled release of macromolecules.

Research Goals
Five goals were established as a guide for this research work. The goals were used
as a basis on which the work was developed. Some o f the goals are as follows:
•

Use layer-by-layer self-assembly to develop a semi-permeable polyelectrolyte
shell around a core;

•

Include a layer o f magnetic nanoparticles in the polyelectrolyte shells;

•

Use an external permanent magnet for “focusing” the core-shell capsules;

1
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•

Use an external alternating magnet for increasing the permeability o f the
polyelectrolyte shells; and

•

Encapsulate a drug in the polyelectrolyte shells embedded with magnetic
nanoparticles for enhanced controlled release o f the drug.

Dissertation Overview
Chapter 2 gives a brief overview o f the background needed for this dissertation. It
covers the different methods used to encapsulate and release macromolecules.
Furthermore, various characterization methods for the encapsulation and release o f the
macromolecules are explained.
Chapter 3 describes the magnetic characteristics o f cobalt, and shows how these
characteristics change as these materials are reduced in size to the nano-scale.
Chapter 4 discusses the nanoshell formation o f the encapsulation o f an anticancer
polypeptide using the layer-by-layer self-assembly technique. Here, the polypeptide is
used as the releasing agent. The polypeptide has a net positive charge due to its amino
acid groups, hence the polypeptide is able to be incorporated in the shells as one o f the
layers itself, allowing for release o f the polypeptide in different pH conditions.
Chapter

5

describes

the

results

obtained

from

incorporating

magnetic

nanoparticles in polyelectrolyte layers to form a semi-permeable shell using layer-bylayer self-assembly. A high molecular weight dextran can selectively diffuse through the
shell with application of an alternating magnetic field. It is shown that these shells can be
“focused” to a specific target using a permanent magnetic field, and then “switched on”
to allow diffusion using a low frequency, alternating magnetic field.
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Chapter 6 builds upon these results be encapsulating micronized dexathemasone
within these semi-permeable shells. The dexamethasone is able to diffuse through these
polyelectrolyte layers naturally due to its low molecular weight. However, by switching
on the enhanced permeability feature o f these shells by applying an alternating magnetic
field, the dexamethasone is able to release at a higher rate.
Chapter 7 concludes the dissertation be giving an overview of the encapsulation
and release techniques used. Future work that can be added to these encapsulation
experiments is also given.
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CHAPTER 2

LITERATURE REVIEW

Nanomedicine, and especially the field o f nanopharmaceuticals (drugs and drug
delivery systems), describe the preparation of nanoscale assemblies, which can be
relatively simple nanoemulsions, nanoparticles, polymer conjugates o f proteins or drugs,
or complex multicomponent systems containing drugs, proteins, or genes, as well as
arrays of targeting ligands and/or signal systems, to enable in vitro or in vivo detection.
Therefore, nanopharmaceutics is defined as the science and technology o f nanometer
scale complex drug delivery systems, consisting o f at least two components, one of which
is the active ingredient. In this field, the concept o f nanoscale is seen to range from 1 to
100 nm. Currently, just one nanoparticle product, Abraxane®, an albumin nanoparticle
containing paclitaxel, is FDA approved, but many more are being developed, and are in
phase I, II, or III o f the drug development process. This means that this class o f drug
delivery systems is rapidly growing and is moving from the development o f individual
building blocks to multifunctional, often biomimetic and bioresponsive systems.
These more complex nanosized drug delivery systems are either self-assembling
or involve covalent conjugation of multicomponent systems; for example drugs, proteins,
and polymers. The bioresponsive and/or biomimetic materials used to create such drug
delivery systems typically include synthetic or semi-synthetic polymers, and/or natural
materials such as lipids, polymers, and proteins. One nanosystem that is being proposed
4
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as a drug carrier is nanoshells or nanocapsules because these novel “nanoparticles” can
address the three principal goals o f drug delivery research today: more specific drug
delivery and targeting; greater safety and biocompatibility; and faster development o f
new, safe medicines. Current research in nanoshell drug delivery could lead to, amongst
others, vectors that will overcome the biological barriers for effective gene delivery,
cancer targeting, brain delivery, and the combination of the potential o f antibody
targeting with nanoparticle technology. This would improve drug targeting to the whole
body or cellular and sub-cellular localization o f drugs, proteins, and genes.
The nanoshells most widely studied as potential nanopharmaceuticals are metallic
nanoparticles composed o f a dielectric core coated with an ultrathin metallic layer and
nanoshells formed by electrostatic layer-by-layer (LbL) self-assembly [1],

Metallic Nanoshells
In the past few years, silica-gold nanoshells have emerged as powerful building
blocks for devices in which electromagnetic waves are able to control the nanometer
length scale [2], Due to this unique property, Halas and West, in a series o f clever
experiments, demonstrated how silica-gold nanoshells are uniquely suitable for use in
whole-blood immunoassays, optically triggered drug delivery, and targeted photothermal
destruction o f cancer cells [3], Mie provided the theory explaining this phenomenon [4].
This theory predicts that metallic nanoclusters strongly absorb visible light at a welldefined plasmon-resonance frequency that depends on the particle size and shape, the
presence o f other particles, and the dielectric environment [5]. Due to this phenomenon,
silica-gold nanoshells offer enormous flexibility to tune the resonance frequency by
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varying the relative dimensions o f the silica core and gold shell [6, 7]. In contrast to
solid-core metallic nanoparticles, the resonance o f a silica-gold nanoshell particle can
easily be positioned in the near-infrared region between 800 -

1,300 nm, where

absorption by biomatter is low. Together, with the high degree o f biocompatibility of
these nanoshells, low bioabsorption opens the door to a wide variety o f biological
applications.

Applications in Nanomedicine
In one study, Halas and West showed how near-infrared resonant nanoshells
could be used to enable fast whole-blood immunoassays [8]. For conventional blood
immunoassays, optical tests were performed at visible wavelengths. Because a
purification step needed to be performed to separate out a variety o f unwanted
biomaterials that absorb visible light, the whole procedure could take several hours or
days. In the proposed immunoassay procedure, nanoshells were conjugated with
antibodies that acted as recognition sites for a specific analyte. The analyte caused the
formation of dimers, which modified the plasmon-related absorption feature in a known
way. The presence of analyte was then determined by a fast absorption measurement in
the water window, circumventing the time-intensive purification step.
Gold nanoshells can also be incorporated into temperature-sensitive hydrogels to
synthesize a new type o f composite material that collapses on laser irradiation [3], Upon
irradiation, plasmon excitations are quickly damped, and the electron kinetic energy is
converted into heat through electron-phonon interactions. This fast damping is usually
undesirable, but here the efficient light-to-heat conversion in metallic nanoshells is used
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to shrink the volume o f the hydrogel from a remote location. The absorption cross-section
o f a nanoshell is about a million times larger than that o f a typical molecular
chromophore, and hydrogel collapse thus occurs at relatively low pump-power densities.
By incorporating nanoshells with different resonance frequencies, one can selectively
collapse specific hydrogel volumes. Such remotely addressable hydrogels may find
application in drug delivery and microfluidic valves or pumps.
For example, composites o f thermally sensitive hydrogels and optically active
nanoparticles have been developed for the purpose o f photothermally modulated drug
delivery [3], Copolymers of N-isopropylacrylamide (NIPAAm) and acrylamide (AAm)
exhibit a lower critical solution temperature (LCST) that is slightly above body
temperature. When the temperature o f the copolymer exceeds the LCST, the hydrogel
collapses, causing a burst release o f any soluble material held within the hydrogel matrix.
When gold-gold sulfide nanoshells, a new class o f nanoparticles designed to strongly
absorb

near-infrared

light,

were

incorporated

into

the

poly(NIPAAm-co-AAm)

hydrogels, temperature changes in the hydrogel could be induced with light. Light at
wavelengths between 800 and 1,200 nm, which is transmitted through tissue with
relatively little attenuation, was absorbed by the nanoparticles, and converted to heat.
Using this system, significantly enhanced drug release from composite hydrogels was
achieved in response to irradiation by light at 1,064 nm as shown in Figure 2.1 (see page
8). This system controlled the release o f methylene blue and proteins o f varying
molecular weight.
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Figure 2.1: Release o f bovine serum albumim (BSA) from nonirradiated and irradiated
hydrogels with and without nanoshells. Irradiation was done at 1,064 nm with 164
mJ/pulse, a 7 nanosecond pulse length, and a 10 Hz repetition rate [3],

The nanoshell-composite hydrogels can also release multiple bursts o f protein in
response to repeated near-IR irradiation [3]. If the entire loaded drug is not released
during the initial irradiation sequence, additional bursts of release o f the drug can be
elicited by subsequent irradiation. Once the laser irradiation is stopped, the driving force
for the convective transport of material out o f the hydrogel matrix is removed. During
this time, the drug release is driven by diffusion, and the amount released is much less
than that generated by irradiation. The hydrogel will begin to swell as soon as the laser is
turned off, returning to its equilibrium state. A second irradiation sequence delivered at
this time w ill cause the hydrogel to collapse again, resulting in another burst o f release o f

the drug molecule. In Figure 2.1, such a release pattern for bovine serum albumin (BSA)
is shown. This type o f release profile may be useful in insulin therapy as well as in other
applications where controlled pulsatile release o f a drug is necessary.
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Additionally, it has been speculated that metallic nanoshells could play a role in
future cancer treatments. These particles are small enough to find their way through the
human circulatory system via injection. Bioactive molecules can be attached to the
nanoshell surface to cause selective binding or accumulation o f these particles within a
tumor. Using a near-infrared laser, carcinoma tissue can then be destroyed by local
thermal heating around the nanoshells. For example, by tuning the nanoshells to strongly
absorb light in the near-infrared, where optical transmission through tissue is optimal, a
distribution o f nanoshells at depths near the tissue’s surface can be used to deliver a
therapeutic dose of heat by using moderately low exposures o f extracorporeally applied
near-infrared (NIR) light [9]. In this study, human breast carcinoma cells incubated with
nanoshells in vitro were found to have undergone photothermally induced morbidity on
exposure to NIR light (820 nm, 35 W cm '2), as determined by using a fluorescent
viability stain. Cells without nanoshells displayed no loss in viability after the same
periods and conditions o f NIR illumination. Likewise, in vivo studies under magnetic
resonance guidance revealed that exposure to low doses o f NIR light (820 nm, 4 W cm' )
in solid tumors treated with metal nanoshells reached average maximum temperatures
capable o f inducing irreversible tissue damage {AT ~ 38 °C) within 5 minutes. Controls
treated without nanoshells demonstrated significantly lower average temperatures on
exposure to NIR light {AT < 10 °C). These findings demonstrated good correlation with
histological findings. Tissues heated above the thermal damage threshold displayed
coagulation, cell shrinkage, and loss o f nuclear staining, which are indicators o f
irreversible thermal damage. Control tissues appeared undamaged.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10

Due to all these positive developments, the design and fabrication o f new types of
plasmonic metallic nanostructures have seen a flurry o f activity. In particular, the unique
properties o f nanoshells seem to promise a golden future for metallic nanostructures in
drug delivery, and it will be fascinating to see what other applications arise in the near
future [8-10],

Nanoshells Formed by Polvion Electrostatic
Laver-bv-Laver Self-Assem bly
The Iayer-by-layer (LbL) nanoencapsulation method involves the formation o f an
outer nanothick shell around a core that is stable, permeable, compatible, and allows the
release o f the core material through the shell. In the last decade, electrostatic layer-bylayer self-assembly has been developed as a practical and versatile nanoencapsulation
method to form nanoshells. The core templates may be “passive” (such as 50 - 300 nm
latex or silica), which later will be dissolved, or “active” and functional (such as drug
micro- and nano-crystals). Tailoring o f the different components o f individual particles
becomes important in order to develop these functionalized colloids; i.e. to combine
several properties in one core-shell structure. Because of these advantages, electrostatic
layer-by-layer assembly has the capacity to employ a great variety o f substances as shell
constituents as well as core materials. O f recently, only general aspects o f the method
have been elaborated to demonstrate its potential, and it still has to be further developed
and better understood [1, 11-15].

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

11

Preparation o f LbL Nanoshells
The sequential adsorption o f oppositely charged colloids was reported in a
seminal paper in 1966 by Iler [16]. The technique of LbL self-assembly for thin films by
means o f alternate adsorption o f oppositely charged linear polyions was then further
developed in the early 1990s [17-20], The basis o f the method involves resaturation o f
polyion adsorption, resulting in the reversal o f the terminal surface charges o f the film
after deposition o f each layer.
Layer-by-layer self-assembly can construct an ultrathin film via alternate
adsorption o f oppositely charged polyions, nanoparticles, and biomolecules. The obtained
films have thicknesses in the nanometer range and tunable properties to their
environment, such as permeability, solubility, and morphology [12, 21-24], The
development o f polyelectrolyte microcapsules is based on LbL assembly on nano- or
micro-scale cores, for instance cells, and inorganic or organic particles, including drugs,
which have recently gained intensive attention [17, 25-30],
Cores, with diameters ranging from nanometers to microns, are coated with
alternating layers o f linear polycations, polyanions, and other materials. After dissolving
the cores, hollow microcapsules were gained with ordered walls o f desired composition,
and thicknesses in the range of 5 - 100 nm. The capsules have tunable permeability for
molecules o f different sizes on the basis o f open-and-close mechanisms by adjusting the
environmental stimuli [31-37], These capsules offer broad perspectives in encapsulation,
transport, and controllable delivery o f drugs, minerals, and proteins. Changing the pH
value o f solutions induces the formation o f tiny pores in the nanometer range, which
allows macromolecules to pass through the capsule walls [33, 36]; adjusting solution
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ionic strength or adding organic solvent will also influence permeability [34, 35, 37],
These permeability controls are achieved by changing the charge densities o f linear
polyelectrolytes, which results in relaxing the capsule walls. However, the austere
conditions o f these methods limit the utilization o f them in the biomedical field for
controlled drug delivery applications because they are often not consistent with
physiological conditions that occur within the human body.
As a standard approach for film preparation on a solid planar support, the
following steps are employed [17, 19, 38]:
•

Prepare

aqueous

solutions

o f polyions,

nanoparticles,

or proteins

at a

concentration o f 0.1 - 5 mg/mL, and adjust the pH in such a way that the
components are oppositely charged.
•

Prepare a planar substrate carrying a surface charge for LbL deposition to take
place; for example silicon, glass, or quartz.

•

Carry out alternate immersions o f the substrate in the aqueous solutions for 10
minutes with 1 minute intermediate rinsing in deionized (DI) water. During
rinsing, be sure the DI water has a pH that keeps the respective assembled
materials properly ionized. Optionally dry the substrate using a stream o f nitrogen
after each rinse. Drying may hinder the assembly process, and it is not necessary
for the procedure.

•

Repeat the previous step until all o f the desired layers have been assembled.

Figure 2.2 (see page 13) shows the scheme o f assembly on a two-dimensional, planar
substrate for assembly with polyelectrolytes and nanoparticles.
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Figure 2.2: Scheme o f electrostatic layer-by-layer self-assembly on 2-D substrates with
(top) polycations and polyanions, and (bottom) polycations and negatively charged
nanoparticles.

The steps for layer-by-layer self-assembly on a 3-D microtemplate are similar to
the above procedure with minor modifications [17, 19, 38]:
•

Prepare

aqueous

solutions

o f polyions,

nanoparticles,

or proteins

at a

concentration o f 0.1 - 5 mg/mL, and adjust the pH in such a way that the
components are oppositely charged.
•

Prepare a solution o f microtemplates carrying a surface charge for LbL deposition
to take place; for example glass beads, MnCC^ cores, or micronized drug crystals.
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•

Alternately add the materials used for assembly to the microtemplates for 10
minutes with 1 minute intermediate rinsing by centrifugation in deionized (DI)
water. During rinsing, be sure the DI water has a pH that keeps the respective
assembled materials properly ionized.

•

Repeat the previous step until all of the desired layers have been assembled.

Figure 2.3 gives the scheme o f assembly on a three-dimensional microtemplate, followed
by core dissolution. The core is dissolved with solvents depending upon the type o f core
used in the assembly

Layer-by-Layer
Assembly

Core
Dissolution

Figure 2.3: Scheme o f electrostatic layer-by-layer self-assembly on 3-D microtemplates,
or cores, followed by core dissolution.
These methods provide the possibility o f designing ultrathin multilayer films with
a precision better than one nanometer o f defined molecular composition. To date, these
methods have been used with more than 50 different charged macromolecules. The
polyions predominately used in the assembly are:
•

Polycations: chitosan (CH), gelatin A (GA), poly(allylamine hydrochloride)
(PAH), poly(dimethyldiallylammonium chloride) (PDDA), polyethylenimine
(PEI), poly-L-lysine (PLL), and protamine sulfate C (PS).
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•

Polyanions: sodium carboxylmethyl cellulose (CMC), chondroitin sulfate sodium
salt (CS), deoxyribonucleic acid (DNA), dextran sulfate sodium salt (DS), gelatin
B (GB), heparin sodium salt (HEP), poly(acrylic acid) (PAA), poly(sodium 4styrenesulfonate) (PSS), poly(vinyl sulfate) (PVS), sodium alginate (SA), and
tannic acid (TA).
These charged materials can be combined with enzymes, antibodies, viruses, and

inorganic nanoparticles to produce multifunctional shells in both 2-D and 3-D
nanoassembly processes. The architecture o f these shells can be designed with nanometer
precision to meet different requirements such as thickness, biocompatibility, controlled
permeability, targeting, and optical or magnetic properties.
The only crucial factor for successful deposition is the surface charge reversal
upon deposition of layers, which can be achieved by choice o f proper deposition
conditions. Since then, various polyelectrolyte species could be adsorbed onto the surface
o f solid or liquid materials by means o f electrostatic adsorption, forming layered
structures with unique properties. It has been established that films can contain more than
1,000 polyelectrolyte multilayers [39], The universal character of the method does not
impose any restriction on the type o f poly electrolyte. The multilayers can also produce
diverse shapes when various materials beside polyelectrolytes, such as organic or
inorganic nanoparticles and crystals, biomolecules, lipids, or viruses, are used in the
coating process. Such coatings produce complicated laminated structures. The use of
polymers as the coating component is often advantageous in comparison with
employment o f their low-molecular weight analogues. Mechanical strength, elasticity,
electrical and optical characteristics, and other properties make them unique building
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blocks for the creation o f composite materials. In addition, the incorporation o f proteins
and nucleic acids in multilayer films may lead to applications in biosensors and
biotechnology [34, 40, 41].
The latter may even provide a base for development o f ultrathin multi-step
chemical catalysts or photosynthesis systems mimicking plants. Applications can also be
found in fabrication o f optical devices [42] and gas separation membranes [43], The
efficient use o f this unique multilayer coating is interlinked with investigation o f their
properties. Although the methods of studying multilayer properties are straightforward,
they are very often not applicable, or are too time consuming, because o f the low amount
o f material studied. Additionally, the possible influence o f the surface used as a support
for layer growth further limits these studies. To eliminate the first factor, one should
increase drastically the total surface area of the multilayers, which can be done by using
colloidal particles as templates [44], Dissolution o f the colloidal cores could avoid the
second objection. The derived hollow capsules allow the study o f polyelectrolyte
multilayers at the liquid-liquid interface, which seems to be very difficult while working
on a solid support [18, 45].
After the first publications on nanoshell formation in the 1990s [11-13], the
structure o f nanoshells has been well characterized, and the procedures to increase the
functionality of the nanoshells have been elaborated through efforts o f several research
groups [13, 17, 41]. For example, pore-openings in these polyion multilayers was first
discovered by Mendelsohn et al. [31], and then later applied for enzyme loading into
nanoshells by Lvov and Caruso [13]. This growth, in the extent o f our knowledge
regarding LbL nanoshell fabrication, structure, and properties, has led to noteworthy
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achievements that have many advantages. However, many practical clinical applications
in nanomedicine remain to be developed.

Proving the Nanoshells
For the time-dependent monitoring of LbL assembly in situ, a quartz crystal
microbalance (QCM) is most often used because o f its proven suitability [17, 46, 47],
First o f all, the kinetics o f the adsorption process can be delineated by the QCM
technique, which is indispensable for establishing proper assembly conditions (e.g.
saturation adsorption time). Multilayer assembly is generally characterized by means of
the quartz crystal microbalance technique in two ways: 1) after drying a sample in a
nitrogen stream, the resonance frequency shift is measured and the calculation of the
adsorbed mass is done by the Sauerbrey equation; or 2) by monitoring o f the resonance
frequency during the adsorption process onto one side of the resonator, which is in
permanent contact with the polyion solutions. The Sauerbrey equation is given as

V = - ^ ,
pv

(2.1)

where A f is the change in frequency, Am is the change in mass per surface area, / is the
frequency of the resonator (9 MHz), p is the density o f the quartz (2,650 k g m '3), and v is
the propagation o f sound in quartz (3,340 m s '1). In solution, QCM frequency shifts o f
about 800 Hz are seen for every adsorption cycle, w hich is more than that detected for a

dried film o f PSS/PAH. This difference is ascribed to the strong hydration of the most
recently adsorbed layer. The bound water is included in the film, and is removed after
drying. This means that most polyion films swell by 40 - 60 % before drying, and that
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only 5 - 10 % o f the water remains in polyion films after drying. Figure 2.4 shows the
thickness o f (PSS/PAH)2 (TA/PAH ) 3 films adsorbed on QCM resonators.

(PSS/PAH),(TX/PAII)j QCM Assembly
-

pH ofsolutions «* 4.5 -

1000

758

I
500

250
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>
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>

Layer

Figure 2.4: Frequency shift and film thickness o f each assembled layer for
(PSS/PAH)2 (TA/PAH ) 3 adsorption on QCM electrodes. The first two precursor layers are
PSS/PAH, and the next three layers are TA/PAH. The tannic acid and poly(allylamine
hydrochloride) has an average thickness o f 1.57 ± 0.11 nm and 1.69 ± 0.35 nm,
respectively [45],
To reach a surface charge reversion during linear polyion adsorption, one needs a
concentration greater than 5 - 10 M [46], However, the dependence o f polyion layer
thickness on concentration is not great because in the concentration range o f 0.1 - 5
mg/mL, the PSS/PAH pair yield a similar bi-layer thickness. A further decrease in
polyion concentration (using 0.01 mg/mL) decreases the layer thickness o f the adsorbed
polyion. On the other hand, an increase in the component concentrations to 20 - 30
mg/mL may result in the non-linear (exponential) enlargement o f the growth rate with
adsorption steps, especially if an intermediate sample rinsing is not long enough [48], In
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addition, at the beginning of the alternate assembly process, one often sees non-linear
film growth [46, 49]. Tsukruk et al. [50] explained this as an island-type adsorption o f the
first polyion layer on a weakly charged solid support. In the following 2 - 3 adsorption
cycles, these islands spread and cover the entire surface, and further multilayer growth
occurs linearly. If a substrate is well charged, then a linear growth with repeatable steps
begins earlier.
In addition to measuring weight changes with a QCM resonator, following
changes in the UV/Vis spectra is another simple method to control LbL assembly on
glass or quartz slides. After every other layer, one can measure the sample UV/Vis
spectra and use Beer’s law (absorbance is proportional to the material mass) to judge the
amount o f adsorbed polymer, and whether or not the assembly process is linear with the
number o f adsorbed layers. In Figure 2.5 (see page 20), the UV/Vis spectra for 5 bi-layers
o f PAH/TA deposited on a quartz slide is shown. There is a linear increase o f absorbance
with an increase in the number of layers (see inset); therefore, the mass o f the film
increased linearly as well. The absorbance maximum at 283 nm corresponds to the
neutral form of tannic acid.
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Figure 2.5: The increase in UV/Vis absorbance with an increase in the number of
PAH/TA layers deposited on a quartz slide. The absorbance o f PAH (black, dotted line)
and TA (blue, dashed line) increases with the deposition of material on the quartz slide.
The inset shows the linear increase in layer mass o f tannic acid [45],

Another method to monitor the assembly process is to ensure the reversal of
charge after each polyion coating as shown in Figure 2.6 (see page 21) [51], For this, the
zeta-potential, or surface potential, o f the suspended nanoshells are measured after each
layer has been applied. Because the adsorption is carried out at a relatively high
concentration o f polyelectrolytes, a number o f ionic groups remain exposed at the
interface with the solution, and thus the surface charge is effectively reversed. The
reversed surface charge prevents further polyion adsorption. The microtemplates are then
washed by centrifugation to remove excess free polyions. The surface is then immersed
in a solution o f anionic polyelectrolytes. Again, a layer is adsorbed, but now the original
surface charge (negative) is restored, and the surface is ready for further assembly. These
two steps are repeated alternately until a layer o f the desired thickness is obtained. More
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than two components can be used in the assembly as long as one condition, a proper
alternation of positive and negative charge, is observed [1, 17, 51].
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Figure 2.6: Changes in the zeta potential o f coated dexamethasone (Dexa) particles as a
function of the number o f adsorption steps for capsule compositions of
(Dexa/PDDA)i(PSS/PDDA ) 4 (solid line and solid squares), (Dexa/PDDA)i (Gelatin
A/PDDA)4 (broken line and open squares), and (Dexa/PDDA)i(PSS/Gelatin
A)4(PSS/PDDA)i (solid line and open triangles) [51].
More detailed structural information can be obtained from X-ray and neutron
reflectivity data. X-ray or neutron reflectivity measurements o f polyion fdms show
patterns with profound intensity oscillations, or Kiessig fringes, due to the interference o f
radiation beams reflected from the interfaces [52], From the periodicity of these
oscillations, one can calculate the film thickness (with the help o f the Bragg-like equation
and taking into account refraction phenomena, which are essential at small-angles).
Growth steps o f 1.1 - 2.0 nm for a bi-layer of polyelectrolytes are typical for alternate
linear polyion assembly, and a thickness o f one layer often equals to half o f this value
[53], These values correspond to a polyion cross-section, and show that in one cycle of
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excessive adsorption, approximately a one-monolayer coverage o f the substrate takes
place. The nanoparticle/polyion bi-layer thickness is determined by the diameter o f the
particles. Model fitting of X-ray data gives a surface roughness o f the polyion film on the
order o f 1 nm, while atomic force microscopy and scanning electron microscopy data
reveal a surface roughness o f 1 - 2 nm [52], Polyion films are insoluble in water and in
many organic solvents, and are stable to 250 - 280 °C [54],
The polycation/polyanion bi-layer thickness depends on the charge density of the
polyions. It was shown that more than 10 % o f polyion side groups have to be ionized for
a stable reproducible multilayer assembly via alternate electrostatic adsorption [55]. High
ionization o f polyions results in a smaller step of film growth ( 1 - 2 nm), and lower
ionization gives a larger growth step ( 3 - 6 nm). It can be reached either by adding salt to
a polyion solution (as discussed above for strong polyelectrolytes, such as PDDA and
PSS), or by varying the pH for weak polyelectrolytes [21].

Influence o f the Core on Nanoshell Properties
So far it has been shown that the procedure o f LbL nanoshell formation is a multistep process. Though capsule properties depend strongly on the choice o f polyelectrolytes
employed, adsorption conditions, and the number o f layers, determining the success o f an
experiment is based on the proper choice o f a core for assembly to take place [39]. This is
especially important when fabricating intact capsules consisting only o f the material used
during the coating. The process o f core dissolution should result in 100 % elimination of
the core without affecting the multilayers. In fact, the molecular weight of core
components is typically a hundred times more than that of the polymers forming the
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shell, and the task of complete core removal seems to be complicated from a chemical
point o f view. At present, cores that have been exploited as templates for hollow capsules
can be classified into three groups differing by dissolution properties and chemical
interactions with components o f the shell [39],
The first class of cores are organic cores made of water-insoluble oligomers
including the widely studied melamine formaldehyde (MF) cores dissolvable at low pH
and in some organic solvents, and polystyrene (PS) cores soluble in tetrahydrofuran
(THF) and bio-friendly polylactic acid/polylactic-co-glycolic acid (PLA/PLGA).
The second class o f cores are cores that dissolve into small molecules and ions.
These can be either ionic or molecular crystals soluble in acidic or basic conditions, or in
an organic solvent. At present, different carbonate particles (CaCC>3 , CdCC>3 , and
MnCCh) [32], and SiC>2 particles [56], have been used for multilayer templating. The
main advantage o f exploitation o f such inorganic particles is the absence o f osmotic
stress upon dissolution, and complete elimination of the cores.
The third class o f cores are those subjected to strong oxidation. A biological cell
is a typical example o f this kind o f core. For example, the assembly o f polyelectrolyte
multilayers can be performed using fixed erythrocyte cells as templates [57, 58]. The
removal o f the cell cores can be achieved by oxidation with sodium hypochlorite
solution. The main effect o f changing the core type is that the employment o f a different
core material will result in different permeability properties o f the shell.
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Barrier Properties o f LbL Assem bled Nanoshells
The barrier properties of nanoshells formed by LbL self-assembly depend on film
thickness, ionic strength, charge o f the permeating molecule, temperature annealing,
resealing by additional layers, and chemical modification. If the permeability o f the
polyelectrolyte multilayer is provided by diffusion through the entangled polymer
network, it should scale with the inverse o f the layer thickness. However, most studies
show that the permeability decreases with increasing layer numbers much faster than
expected from a straightforward thickness increase. Only from approximately eight layers
onward does the permeability multiplied by the shell thickness become constant,
indicating that the permeability is now controlled by the thickness increase, and the
diffusion-limiting region is the properties o f the polyelectrolyte layer [59], Normally, the
deeper layers are denser resulting in a five-fold reduction o f the estimated diffusion
coefficient, while the loose structure o f the interfacial layers leads to a very slow increase
in the dissolution time. This means that only presence o f the internal dense layers can
slow down the dissolution time. For thinner walls, the drastic dependence on shell
thickness may be explained either by the existence o f pores that are successively closed
by further layer deposition, or by a thickness dependent diffusion coefficient. Diffusion
dependent on layer depth was indeed observed when the diffusion o f polar labels in
planar polyelectrolyte films was studied [59],
Another parameter that can influence the multilayer structure is the ionic strength
[39], It has been shown that the multilayer structure is affected if the salt concentration is
changed once the film is built up. Polyelectrolyte multilayer vesicles can be subjected to
temperature treatment, which significantly influences their properties. For example, at
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temperatures up to 95 °C, the polyelectrolyte capsules keep their integrity, but undergo
irreversible structural changes [60], The resulting structure is characterized by decreasing
the capsule diameter while simultaneously increasing the shell thickness as revealed by
scanning force microscopy. From a thermodynamic point o f view, this effect can be
explained by approaching the equilibrium state o f the polyelectrolyte complexes. In
another example, hollow capsules were fabricated by LbL deposition of oppositely
charged diblock co-polymers each containing a poly(N-isoproprylacrylamide) (PNIPAM)
block and a charged negative or positive block (20 mol %) [61]. PNIPAM is known to
undergo a phase transition at a temperature o f 32 °C (lower critical solution temperature),
after which it is not soluble. This transition is rather sharp and completely reversible upon
cooling. The obtained capsules exhibit changes in morphology and permeability at
elevated temperatures. However, this process is only partially reversible in the
multilayers. Relaxation requires more than a month, which limits their thermosensitivity
to one heating circle.
Chemical modification can be another way to induce the excessive charge into the
polyelectrolyte multilayers and change other characteristics o f the film. One method
proposed is using poly(acrylic acid), partially modified by Fisher esterification with
different alcohols, as a multilayer constituent [62]. Depending on the nature o f the
derivatizing alcohol, the hydrophobicity of the film could be tuned. The hydrophobicity
o f ester groups was shown to result in advancing water contact angles to more than 100
degrees. Cross-linking o f these hydrophobic films via heat-induced amidation stabilized
coatings over a wide pH range, but did not significantly influence their permeability. It
has been proposed that cross-linking o f the reactive groups in the multilayers is
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sometimes the only possibility o f making films composed of weak polyelectrolytes stable
at a wide range of pH and ionic strengths. One example is PAA/PAH multilayers, which
readily decompose upon shift of pH or ionic strength, which can be crosslinked in order
to gain stability [63], In contrast, nanoshells composed of PSS/PAH multilayers have
semi-permeable properties [38], They are permeable for small molecules, such as dyes
and ions, while under most conditions the high molecular weight compounds are
excluded. One o f the explanations for this is the much smaller size o f the pores in the
multilayer film in comparison to the hydrodynamic radius of the permeating molecules.
Filled capsules can also serve as microreactors [34], This is advantageous because
encapsulating enzymes and proteins in macromolecules shields them from inhibitors.
This means the activity o f enzymes encapsulated is higher as compared with typical
values o f chemically immobilized enzymes. In addition, the native conformation of
proteins, such as hemoglobin, does not change with encapsulation due to contact with
nanoshells because there is no change registered in a position o f the Soret band, which is
very sensitive to changes in the heme conformation. All of these studies showed that the
possibility exists to control the capsule permeability as shown in Figure 2.7 (see page 27).
This can be desirable for many applications, including drug delivery. This means that the
exploration o f the permeability properties o f capsules and multilayers must be further
developed because it promises many possibilities as drug carriers, biosensing, micro
reactors and catalysts, construction materials, and many others [59].
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Figure 2.7: (left) Confocal image o f polyelectrolyte microcapsules with a wall
composition o f (PSS/PAH ) 5 loaded with FITC-labeled glucose-oxidase, and (right)
atomic force microscopy tipping mode image o f the same broken dry capsule on mica.
Release o f the encapsulated material is visible [34],

Controlled Release o f Active Pharmaceutical Ingredients
Encapsulated by LbL Assem bled Nanoshells
A major challenge in the development o f carrier systems o f submicron
dimensions lies in the field o f advanced drug formulations, especially when it comprises
the elaboration o f delivering systems capable to provide sustained release o f bioactive
materials [39]. Mainly, these bioactive compounds are small molecules with different
solubility and diffusion coefficients. If we consider only physical entrapment without any
covalent binding in order to develop a delivery system, one has to encapsulate the active
molecules within the shell proving certain release characteristics. The potential use of
polyelectrolyte capsules with drug entrapped in the nanoshell for controlled drug delivery
currently requires more study and is not well established. In contrast, micro
encapsulation o f drug microparticles is a well established technique for prolonging
release. When microcapsules are coated with appropriate antibodies, they can also be
targeted to specific regions in the body. This can lead to lowered overall dosage
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requirements, increased drug concentrations in the needed regions, and reduced side
effects.

Polymer-based and liposome-based

systems have been used

for drug

encapsulation, mostly as unordered drug/polymer conjugates [64-67],
The LbL self-assembly technique based on alternate adsorption o f oppositely
charged components was developed to add nanometer-thick films to surfaces [11, 12, 31,
68, 69], offering the opportunity to design controlled release systems by encapsulating
micron-scale cores with a very thin outer shell. The core must be insoluble under some
conditions, such as low pH, and soluble under the conditions at which controlled release
is to take place. The release rate generally depends on the thickness o f the encapsulating
shell and the material used in the coating. Thicker shells lead to longer release times.

Nanoshell Permeability for Low Molecular Weight Compounds
In the first report on controlled release, fluorescent dye microcrystals were used
as a model system for controlled release studies [19]. Poly(sodium 4-styrenesulfonate)
(PSS) and poly(allylamine hydrochloride) (PAH) were used to form a polyelectrolyte
shell on the fluorescein core. Increasing the number of layers decreased the shell
permeability and resulted in prolonged dye-core dissolution. Encapsulation o f ibuprofen
also resulted in prolonged release at different pH values [70], The ibuprofen dissolution
time from capsules with walls built from 15 bi-layers o f chitosan/dextran was 40 seconds
at pH 7.4, compared to 10 seconds with no coating. Therefore, prolongation of the release
was minimal.
To determine whether encapsulation by LbL assembly can substantially increase
drug release times, the technique was used to assemble polypeptides and polyions on
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microcrystals o f 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoic acid,
commonly known as furosemide [17]. Furosemide is a diuretic and anti-hypertension
drug that is practically insoluble in water. Although the therapeutic effect is fast and
intense after oral administration o f furosemide, the oral bioavailability o f the drug from
an immediate release dosage form is poor and highly variable [71]. These problems can
potentially be overcome by developing a modified release dosage form. Ai et al.
encapsulated furosemide microcrystals with polyions and gelatin to control the release of
the drug in aqueous solutions (Figure 2.8, see page 30) [17]. In step 1, precursor layers of
(PSS/PDDA)2 were assembled onto positively charged furosemide microcrystals. In step
2, (PSS/Gelatin)2 -6 layers were added via LbL self-assembly. In step 3, drug release in
aqueous solution was monitored at different pH values. Charged linear polyions and
gelatin were alternatively deposited on 5 pm drug microcrystals through LbL selfassembly. Sequential layers o f poly(dimethyldiallylammonium chloride) (PDDA) and
poly(sodium 4-styrenesulfonate) (PSS) were followed by adsorption o f two to six
gelatin/PSS bi-layers with corresponding capsule wall thicknesses ranging from 45 to 115
nm. Furosemide release was then determined from the LbL encapsulated crystals under
two physiological pH conditions, pH 1.4 (stomach) and pH 7.4 (blood). At both pH
values, the release rate o f furosemide from the encapsulated particles was reduced by 50
- 300 times (for capsules coated with 2 - 6 bi-layers) compared to uncoated furosemide.
The results provide a method o f achieving prolonged drug release through self-assembly
o f polymeric nanoshells on drug microcrystals.
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Figure 2.8: (a) Illustration of the furosemide microcrystal encapsulation and release
study, and (b) dissolution profiles o f (PSS/PDDA)2(PSS/gelatin ) 4 coated furosemide
microparticles compared to uncoated particles and a commercially available tablet in
physiologically relevant media [17]. Here, 1 corresponds to 100 % release on the fraction
o f drug released axis.
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In a study that further expanded the application o f core-shell structures fabricated
by electrostatic layer-by-layer self-assembly for drug delivery, Pargaonkar et al. reported
the controlled release of dexamethasone from microcrystals encapsulated with a
polyelectrolyte shell [51]. The LbL self-assembly process was used to produce
dexamethasone particles layered with (PDDA/PSS)4 PDDA, (PDDA/Gelatin A)4PDDA,
(Dexa/PDDA)i(Gelatin B/PDDA)4, or (Dexa/PDDA)i(PSS/Gelatin A)4(PSS/PDDA),.
The nanothin shells were characterized by quartz crystal microbalance measurements,
microelectrophoresis, microcalorimetry, confocal laser scanning microscopy, and
scanning electron microscopy. The in vitro release o f dexamethasone from the
microcapsules suspended in water or carboxymethyl cellulose gels, measured using
vertical Franz-type diffusion cells, showed that the assembly o f multiple polyelectrolyte
layers around these monodispersed cores produced a polyelectrolyte multilayer shell
around the drug microcrystals, which allowed for controlled release depending on the
composition and the number of layers.
Sonication o f dexamethasone during the layering process helped to reduce the
particle size o f the drug, thereby increasing the dissolution rate o f this practically water
insoluble drug while also increasing the suspension stability [51]. For negatively charged
micronized dexamethasone particles, the effective adsorption o f a first layer o f PDDA
during sonication, as evidenced by microelectrophoresis measurement o f the reversal in
charge, caused enhanced dispersability o f the dexamethasone particles because o f the
colloidal stabilization produced by the positively charged PDDA coating combined with
a significant reduction in particles size to below 2 pm. Stabilizing o f the practically
monodispersed particles also reduced the Ostwald maturation, or the phenomenon where
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small particles gradually increase in size, o f the colloidal particles o f the scarcely soluble
dexamethasone, thereby preserving the reduction in particle size, and the integrity and
shape o f the original crystals. A schematic of this process is shown in Figure 2.9.
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Figure 2.9: Illustration o f the monodispersion o f micronized dexamethasone drug
particles by electrostatic layer-by-layer encapsulation, followed by subsequent controlled
release of the drug through the insoluble porous shell [51].
Y e et al. showed that indomethacin microcrystals can be directly encapsulated
with polysaccharides, sodium alginate, and chitosan multilayers through the LbL selfassembly method [72], The retention of the drug microcrystal was found to gradually
decrease due to its partial dissolution in the deposition solution. It was very significant
that increasing deposition temperature from 20 - 60 °C reduced the release rate
efficiently, owing to the increase in multilayer thickness and formation o f a more ordered
multilayer film. This finding provides a new and simple method to control the
permeability o f the LbL assembled multilayer films.
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Nanoshell Permeability for High Molecular Weight Compounds
Deoxyribonucleic acid (DNA) and polynucleotides can be readily assembled in
alternation with polycations [73], Alternate adsorption o f 0.1 mg/mL DNA at pH 5.2 with
polycations gave multilayers with a DNA/PEI bi-layer thickness o f 4.4 nm and
DNA/PAH bi-layer thickness o f 3.6 nm. Fourier transform infrared (FTIR) spectra
confirmed the native doublestranded DNA conformation in DNA/PEI and DNA/PAH
multilayers. Coating DNA/polyion films on medical implants may have applications in
local gene therapy. In other studies, proteins including lysozyme, horseradish peroxidase,
albumin, bacteriorhodopsin, immunoglobulins, glucoamylase, glucose-oxidase (GOx),
catalase, glucose isomerase, and diaphorase were used at a concentration o f 0.1 - 2.0
mg/mL for LbL assembly [1]. Because the surface structure o f the solid support can
affect the stability of the proteins, precursor films o f alternate PEI/PS S are normally used
as standard surfaces. Proteins immobilized in multilayers with strong polyions, such as
PSS, PEI, and PDDA, are insoluble in buffers in a pH range between 3 and 10. Protein
multilayers with weak polyions are partially soluble in solutions with a pH close to the
isoelectric point o f one of the components, but such multilayers can be stabilized with
crosslinking agents. Assembled proteins are in most cases not denatured [74, 75].
Nano-organized

encapsulation

of

protein

microcores,

such

as

insulin

nanoparticles in the presence o f a high concentration of neutral polymers, was also
elaborated with LbL assembly. Uncoated insulin PROMAXX® microparticles formed by
controlled phase separation from hydrophilic compounds undergo to a fast dissolution if
the poly(ethyl glycol) (PEG) concentration is decreased [76]. Insulin release from
PROMAXX® was extended with LbL encapsulation. After the complex o f insulin in the
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core, and the first layer of oppositely charged polymer, is formed, the microparticle is
stabilized, and adding new polyelectrolyte layers can be continued. Balancing strong
interactions o f the first polyelectrolyte layer with protein microcores, and easing this
interaction

by

depositing

the

second

oppositely

charged

polyelectrolyte

(polyanion/polycation for positive cores at pH 5.8, and polycation/polyanion for negative
cores at pH 7.0), gave the ability to control complexation o f the encapsulated proteins,
and to reach a sustained insulin release. Fine tuning of the release profile was reached by
using additional polyelectrolyte layers.
Therefore, the general idea o f the controllable complex formation is as follows:
adsorption o f the first polyelectrolyte layer results in strong complex formation and very
slow release. An addition of the second, oppositely charged polyelectrolyte layer, results
in a relaxed complex and quicker release. The third oppositely charged layer again gives
slower release, and so on. Simply growing the thickness of the capsule walls within 5 10 bi-layers (30 - 60 nm) did not slow insulin release from the microparticles. With this,
the concept formulated by Mohwald et al. [18, 19, 34], defining LbL multilayers as a
tight diffusion barrier with adjustable thickness in the range o f 5 - 12 bi-layers, was
converted to a new approach where the main role in the controlled release from protein
micro-aggregates is given to adjustable interpolyelectrolyte complex formation controlled
by alternate polycation/polyanion coatings o f 2 - 3 monolayers.

Magnetic Nanoshells
By using LbL assembly, it is also possible to include magnetic nanoparticles, such
as magnetite, into the shell, thereby making the entire capsule magnetic. This is shown in
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Figure 2.10. In this example, a 400 nm diameter capsule was composed o f a glucoseoxidase core covered with a shell composed o f two bi-layers o f 12 nm diameter magnetite
alternated with cationic PEI. Deposition o f magnetite nanoparticles provided a magnetic
momentum that allowed the nano/bio reactors to be self-stirred, and even be separated by
the application o f an external magnetic field [77].

Figure 2.10: A
400 nm
diameter glucose-oxidase
core
coated with
(PSS/PEI)2 (Magnetite/PEI) 2 shells. The 12 nm diameter magnetite nanoparticles are
visible on the surface.

The magnetic fluid hyperthermia (MFH) method applies a high frequency
alternating magnetic field to heat superparamagnetic nanoparticles localized in a tumor to
destroy diseased cells without damaging healthy tissue [78-80]. In this technique,
magnetic nanoparticles are injected in a local tumor site. A high frequency magnetic field
agitates the particles rapidly to generate local heating at the tumor site. This localized
heating destroys the tumor cells.
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CHAPTER 3

PROPERTIES OF MAGNETIC
PARTICLES

Bulk magnetic materials exhibit well-known magnetic properties; however, as
these materials are shrunk to the nano-scale their properties change due to the decreased
number o f domains per particle.

Magnetism in Bulk Materials
Magnetic Anisotropy
Many magnetic materials have a preference for the direction in which the
magnetization lies. This preference is known as magnetic anisotropy, and is dependent on
the sample shape, crystal symmetry, stress, and directed atomic pair ordering [81, 82],
The uniaxial crystal anisotropy energy density for a magnetic material, jila, can be
expressed as

(3.1)

where Ku is the uniaxial anisotropy energy density. The uniaxial crystal anisotropy
energy density can be simplified to three terms giving
(3.2)

36
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Kuo = 0 for anisotropic properties because it is independent o f the orientation o f the
magnetic movement. For cobalt, at room temperature, Kui and K u2 where experimentally
found to be 4.1 x 105 J m '3 and 1.5 x 105 J m '3, respectively [81]. Table 3.1 gives a list of
magnetic anisotropy constants for selected materials [81].

Table 3.1: Magnetic anisotropy constants, Ki and K 2 ,for selected materials in J m '3 [81].
Kui and K„2 , for cobalt, are listed under K/ and K 2 , respectively.

(T = 4.2 K)
Kt
Fe
Cou
Ni
Fe3C>4
uK ui

5.2
7.0
-12.0
-2.0

X
X
X
X

(r=300K)
K2

104
105
104
104

-1.8
1.8
3.0

X
X
X

K,
104
105
104

4.8
4.1
-4.5
-0.9

K2

X
X
X
X

104
105
103
104

-1.0
1.5
-2.3

X
X
X

10'
10:
10

and K u2 are listed under Kj and K2, respectively.

Plugging in these values for cobalt, the uniaxial crystal anisotropy energy density
becomes
(i0 = 4 .1 x 1 0 s sin2 0 + 1.5 x lO 5 sin4 0 ,

(3.3)

where jua is in terms o f J-m'3. A graph o f the uniaxial crystal anisotropy energy density is
given in Figure 3.1 (see page 38). When a magnetic field is applied, the magnetization
seeks the lowest energy orientation along the ± z-axis, or easy axis.
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Figure 3.1: Anisotropy energy surface for cobalt. Cobalt naturally aligns to the z-axis, or
easy-axis, because that is where the lowest anisotropy energy is located.

Magnetic Domains
Magnetic materials are composed o f several magnetic domains throughout the
material, each o f which has a separate magnetization. The combined magnetization of
these domains gives the material a net magnetization, which is observable on the macro
scale. Soft magnetic materials consist o f many randomly orientated domains, which give
the material a net magnetization o f nearly zero when no external magnetic field is present
[81].
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Domains are formed to reduce the magnetostatic energy o f a finite, uniformly
magnetized sample. For uniaxial anisotropy materials, such as cobalt, the magnetization
vectors in adjacent domains are antiparallel to each other, or 180° to each other. The
energy is reduced by a gradual reversal in direction over N atomic distances within the
domain wall, where at one domain boundary 6(z) approaches 0, at the center o f the
domain wall 6(z) is rc/2, and at the opposite domain boundary 6(z) approaches n as shown
in Figure 3.2.

U

ft

Figure 3.2: Schematic o f a ferromagnetic material containing a 180° domain wall.
Domain #1 (blue arrows, left) and domain #2 (red arrows, right) have magnetization
vectors 180° to each other. The domain wall (middle arrows) is composed of N atomic
distances, and is where the transition from one domain to another takes place.

The analytical form for the magnetization orientation profile, 0(z), is given by

6(z) = - arctan sinh

K
+T
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where z is the distance in nm and 8 is

8=71

(3.5)

where A is the exchange stiffness constant and K u is the uniaxial anisotropy energy
density. The domain wall thickness, 8dw, can also be calculated using
f AA V/2

(3.6)

This is equal to 8 given in Equation 3.5. A graph o f the magnetization orientation profile,
along with the domain wall thickness, is given in Figure 3.3 (see page 41) for cobalt. The
exchange stiffness constant and uniaxial anisotropy energy density are 1 x 10"11 J-m'1 and
4.1 x 105 J-m'3, respectively, for cobalt [81]. The domain wall thickness for cobalt is
calculated to be approximately 15.5 nm. As the size o f magnetic particles is reduced to
the nano-scale, the number of domains in the material decreases to one, and no domain
wall exists.
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Figure 3.3: Graph showing the magnetization orientation profile and the domain wall
thickness for cobalt. The magnetization orientation profile is represented by the red line,
and the domain wall thickness, SdW= 15.5 nm, is shown in blue.

Magnetism in Nano-Scale Materials
Definition o f Nano-Scale Materials
Nano-scale materials can be defined as materials with one or more dimensions in
the nano-regime, or less than 100 nm in each dimension. These materials have unique
properties not achievable in their bulk form [81]. A 1-dimensional nano-scale material
would have one of its dimensions less than 100 nm, for example a thin-film (Figure 3.4a,
see page 42); a 2-dimensional nano-scale materials would have two o f its dimensions less
than 100 nm, for example a rod (Figure 3.4b, see page 42); and a 3-dimensional nano
scale material would have all three o f its dimensions less than 100 nm, for example a
nanoparticle (Figure 3.4c, see page 42).
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Figure 3.4: (a) 1-dimensional, (b) 2-dimensional, and (c) 3-dimensianal nano-scale
materials represented by stacked thin-fdms, rods, and particles, respectively. The small
dimensions are 100 nm each. Here, the large dimensions are 1 |im each; however, any
dimension over 100 nm is considered a large dimension for nano-scale objects.

Superparamagnetism
The superparamagnetic particle size limit, ro, can be defined as
(
ro =

9kJ

A/3
(3.7)

where kb is the Boltzmann constant (1.38 x 10'23 J-K'1), T is the temperature in degrees
Kelvin (room temperature is ~ 300 K), and K u is the uniaxial anisotropy energy density
(4.1 x 105 J-m'3 for cobalt). For cobalt, this limit is approximately 4.4 nm in diameter.
Similarly, the single-domain limit, rc, can be calculated as

r , = 9^

,

(3.8)

where A is the exchange stiffness constant (1 x 10"11 J-m'1), fXo is the free space
permeability constant (4tc x 10'7 H-m'1), and Ms is the magnetic saturation in A m '1.
Using Equation 3.8, fioMs can be plotted as a function o f rc to obtain the critical radius of
cobalt as shown in Figure 3.5 (see page 43).
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Figure 3.5: Critical radius for single-domain behavior versus saturation magnetization for
spherical particles o f cobalt. The blue line shows rc for 0 - 5 0 0 nm, the red line zooms in
to show rc for 0 - 1 0 0 nm, and the green line zooms in further to show rc for 0 - 10 nm.

The size o f a magnetic particle cannot be reduced indefinitely because the
particle’s useful magnetic properties will diminish [81]. Below the superparamagnetic
particle size limit, thermal energy may be large enough to overcome the magnetization of
the particle. For these small particles, magnetization is spontaneous, and demagnetization
occurs as quickly as an external field is turned off [81]. The magnetization is uniform
over the entire particle at any instant. These superparamagnetic particles have a larger
response to an external magnetic field than paramagnetic material because the local
moment has a magnitude of N 'fim instead o f flm, and the susceptibility o f a
superparamagnet is increased (A ^-fo ld [81].
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Hysteresis curves of superparamagnetic particles resemble those o f ferromagnetic
materials with two unique differences [81]:
•

the approach to saturation follows a Langevin behavior; and

•

there is no coercivity.

Superparamagnetic demagnetization occurs without coercivity because it is not the result
o f an applied magnetic field, but o f thermal energy. The demagnetization effect of
superparamagnetic materials indicates that these materials have no memory, and have the
ability to disperse without the application o f external magnetic fields; whereas
ferromagnetic materials tend to retain memory, even after the external magnetic field is
removed, leaving the particles magnetically attracted to each other.
Superparamagnetic particles will be used in this work to enhance the release of
macromolecules through polyelectrolyte shells fabricated via layer-by-layer selfassembly. These particles will allow the capsules to be “focused” to a specified location
using a permanent magnet through magnetic attraction, and “switched on” using low
frequency, alternating magnetic fields by agitating the particles in the polymer matrix.
The release conditions are novel in that the release does not depend on physiological
conditions within the body, but on external magnetic fields, which can be applied when
needed, transforming polyelectrolyte microcapsules into nano/bio robots for enhanced
drug release.
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CHAPTER 4

RELEASE OF PHOR21-(3CG(ALA) POLYPEPTIDE
INCORPORTATED IN A POLYELECTROLYTE
SHELL

Introduction
The use of layer-by-layer (LbL) nanoassembled multilayers as drug carrier
systems has been studied widely by a number o f research groups. Typically, drugs were
loaded in polyelectrolyte nanocapsules, where adjustable, self-assembled, multilayer
walls served as diffusion barriers giving 1 - 4

hours release time [17, 70, 72], The

procedure was useful for drugs that do not aggregate and lose their potency at higher
concentrations. Less attention was given to the inclusion of drug molecules as an intrinsic
component o f the multilayers by alternating the assembly o f the drug molecules with
oppositely charged polyelectrolytes. Such an approach could avoid the preparation o f
highly concentrated drug suspensions. Being tightly bound within the polyelectrolyte
multilayers, such drug molecules could be released much slower in a sustained fashion,
thus retaining their biological activity. Different kinds o f dye molecules (indoine blue,
chromotrope 2R, methylene blue, rhodamine 6G), as well as plasmid DNA induced in the
polyelectrolyte multilayers, have been investigated for their release according to varying

45

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

46

environmental conditions [83-87], Numerous studies have been concentrated on the
stability o f self-assembled polyelectrolyte layers on either planar or spherical surfaces;
and further studies have been directed to the possibility of assembling drugs directly in
the polyelectrolyte layers for delivery. The polyelectrolyte layers can prevent peptide
degradation through proteolysis, and can serve as a storage device.
Most of the current LbL drug delivery studies have been conducted on planar or
spherical surfaces with polyelectrolyte materials as the controlling release membrane.
Nanoparticles have recently shown great promise in biomedical and biotechnological
applications. The nanometer size ranges o f the particles offer distinct advantages for drug
delivery; nanoparticles can penetrate deep into tissues through fine capillaries. Common
materials used in nanoparticle fabrication include iron oxide, gold, silica, and polymers.
For silica, its surface can be modified to contain avidin, sulfide, amine, or carboxylate
groups, which facilitate not only in bioconjugation, but introduce surface charges for LbL
nanoassembly. Up to now, silica nanoparticles have been widely applied in the
biomedical field, such as in biomarkers for cell imaging, biosensor applications, DNA
detection and protection, etc. [88, 89]. Flere, silica nanoparticles were used as model drug
carriers to study the release o f Phor21-pCG(ala) drug molecules introduced in the
nanoshells.
Phor21-pCG(ala) is an anticancer polypeptide used to treat breast tumors [90]. In
this study, a newly developed membrane disrupting peptide, Phor21, was used, which is
more potent in destroying cancer cells than Hecate or Phorl4. Phor21 is a membrane
disrupting lytic peptide, similar to those identified as defense agents in insects,
invertebrates, vertebrates, and humans [90], Phor21-pCG(ala) contains 36 amino acid
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residues,

with

an

amino

acid

sequence

of

KFAKFAKKFAKFAKKFAKFAK-

SYAVASAQAALAARR. The conjugated gonadotropin ligand, pCG(ala), with an amino
acid sequence o f SYAVASAQAALAARR, facilitates and increases the cell selectivity of
the lytic peptide. In the pCG(ala) fragment, the cysteins were replaced by alanines, which
increased the synthetic yield o f this fragment. The calculated isoelectric point o f the
peptide is 11.4.
In this work, multilayer nanoshells o f the cationic peptide Phor21-pCG(ala),
assembled in alternation with biocompatible, biodegradable polyanions like gelatin B and
sodium carboxymethyl cellulose on silica core nanoparticles, were studied. Furthermore,
multilayer decomposition and peptide release with characteristic times o f 20 - 30 hours
were analyzed.

Materials and Methods
Sodium carboxymethyl cellulose (CMC, MW 90,000 dal) and gelatin from bovine
skin, type B (Gelatin B, MW 20,000 - 25,000 dal) were purchased from Sigma Aldrich
and used without further treatment. Anticancer lytic polypeptide Phor21-pCG(ala) (MW
4,010 dal) was obtained in the lyophilized form from the National Cancer Institute
(Bethesda, MD). Silica nanoparticles (diameter 450 nm ± 30 nm) were purchase from
Polysciences Inc. in a 5.7 % aqueous dispersion. The release media used in this work was
0.9 % sodium chloride injection USP solution (B. Braun Medical Inc., pH 5.6).

Preparation o f Silica-Peptide Nanoshells
Deposition

of

polyelectrolyte

multilayers

on

silica

nanoparticles

was

accomplished using a procedure elucidated elsewhere [13, 91]. In this case, CMC and
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gelatin B were negatively charged, while Phor21-|3CG(ala) was positively charged in
deionized (DI) water. Typically, CMC or gelatin B (0.5 mL of 2 mg/mL in 0.2 M NaCl)
and Phor21-(3CG(ala) solutions (0.5 mL o f 1 mg/mL in 0.2 M NaCl) were alternately
added into 1.5 mL silica particle suspensions (20 mg silica total mass). Adsorption o f the
polyelectrolyte layer was completed within 30 minutes at 4 °C. Subsequently, three
intermediate washings with DI water were made at 4 °C using centrifugation at 2,000
RPM for 10 minutes before the addition of the next layer to remove any remaining
polyelectrolytes or peptide from the supernatant solution.

Characterization o f Silica-Peptide Nanoshells
The assembly o f layers on silica nanocores was confirmed by monitoring quartz
crystal microbalance resonance frequency changes (QCM, USI-Systems, Japan), and
determining the changes o f the electrophoretic potential (^-potential) after deposition of
every layer using a zeta potential analyzer (Brookhaven Instruments Corporation). After
the desired number of layers was obtained, the assembled cores were lyophilized or
stored at -20 °C before use.
The amount o f peptide adsorbed on the nanoparticles was monitored using
UV/Vis absorbance (Agilent model 8543). A 500 pL solution of 1.0 mg/mL peptide was
added into 1.5 mL of 20 mg silica nanoparticle suspensions. After 30 minute adsorption
of peptide on silica cores, the cores and solution were centrifuged at 2,000 RPM for 8
minutes and the obtained supernatant was centrifuged again at 5,000 RPM for 10
minutes. The absorbance o f the supernatant was checked using UV/Vis at 281 nm. The
amount o f Phor21-pCG(ala) adsorbed on the cores was calculated by subtracting the
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original concentration of peptide with the amount of peptide remaining in the
supernatant.

Release Kinetics I n V itr o
In the peptide release experiments, first the peptide release was evaluated using
negatively charged planar glass slides: 20 layers of peptide were alternatingly coated on
slides with CMC. The initial and final peptide concentrations were detected by UV/Vis;
the amount o f peptide adsorbed on the slides was then calculated using the difference of
the peptide concentrations. Then, the release kinetics were determined in 0.9 % NaCl
USP injection media at 37 °C. The peptide coated glass slides were immersed in the
release media while stirring at 800 RPM. The UV absorbance o f the release media was
measured after certain time intervals by removing the slides. The percentage o f peptide
released was calculated.
In the second stage, for the peptide released from silica nanoparticles, a similar
procedure was carried out to examine the amount o f peptide adsorption as mentioned
above. A 20 mg batch of silica nanoparticles (15 mg/mL) was coated with a certain
number o f peptide layers and added into a 2.0 mL release buffer in a centrifuge tube (in a
37 °C water bath) with continuous stirring at 800 RPM. At certain time intervals, a 0.5
ml particle suspension was centrifuged at 5,000 RPM for 10 minutes. The supernatant
was checked using UV/Vis with a UV absorbance at 281 nm, and the supernatant was
transferred back into the original suspension.
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Results
First, the assembly o f Phor21-pCG(ala) with CMC and gelatin B on 450 nm SiC>2
nanoparticles was elaborated, and the surface charge using a ^-potential analyzer was
analyzed.

Figure 4.1

describes the basic nanoparticle

assembly

with

Phor21-

pCG(ala)/(CMC or gelatin B) coatings.

Figure 4.1: Scheme o f Phor21-pCG(ala) adsorption on 450 nm silica nanoparticles, and
the release o f the drug (large, blue spheres = silica cores; small, red dots = Phor21pCG(ala) peptide; and wavy, green lines = polyelectrolytes).
Figure 4.2 (see page 51) shows the alternation o f ^-potential o f the particles with the
adsorption o f each polyelectrolyte layer. After the washing steps, the silica nanoparticles
had a ^-potential o f -70 ± 10 mV. The Phor21-pCG(ala)/CMC adsorption followed the
general scheme of alternate adsorption o f oppositely charged linear polyelectrolytes [12,
13]. After adsorption o f the cationic peptide, the surface potential became positive (+20 ±
3 mV); after consequent deposition o f anionic CMC, it became negative (-48 ± 4 mV);
and so on until the shell reached a certain number o f polyelectrolyte layers. The core

surface charges totally reversed during the adsorption process. However, this is not the
case when alternating adsorption was conducted using Phor21-pCG(ala) with gelatin B.
In this case, with the exception o f the first peptide layer, the surface charges did not
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totally reverse when the peptide was adsorbed on the cores. The surface charges o f the
peptide layers remained negative (ca. -10 mV) during the assembly and adsorption
process.

Zeta Potential Variation vs. Layer Growth
of PhortI-#CG<ala>CMC on Silica Cores
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Figure 4.2: Zeta potential o f the silica nanoparticles demonstrating the surface changes
during adsorption o f Phor21-pCG(ala) alternating with (a) sodium carboxymethyl
cellulose and (b) gelatin B. The error bars represent one standard deviation from the
mean.
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The assembly results of the peptide and polyelectrolytes on QCM resonators are
shown in Figure 4.3a (see page 53), which monitored the process by the weight addition
on every deposition cycle. The plot shows a stable growth o f Phor21-|3CG(ala) layers
alternated with polyanions on QCM resonators. The QCM frequency shift plot in Figure
4.3a (see page 53) shows that the formation o f the multilayers corresponding to the
planned wall composition o f the silica nanoshells, and the layer growths, was rather
linear on QCM resonators. The average thickness of peptide layers alternating with CMC
was estimated as ca. 0.81 ± 0.18 nm using the Sauerbrey equation [13, 92], The mass o f
one peptide layer on 20 mg silica nanoshells thus could be estimated as ca. 0.10 ± 0.02
mg using the QCM data, reaching adsorption efficacy o f 20 %. The average thickness of
peptide layers was ca. 0.72 ± 0.37 nm. The calculated mass of one peptide layer on 20 mg
silica nanoparticles was ca. 0.09 ± 0.02 mg from the QCM data. These values were
consistent with the results obtained from peptide/CMC adsorption.
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QCM M ast and Thickness Variations
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Figure 4.3: (a) QCM and (b) UV/Vis data showing the peptide adsorption on QCM
resonators and 450 nm silica particles, respectively. For the UV/Vis data, the peptide
assem bly was alternated with CMC. The error bars represent one standard deviation from

the mean.
Figure 4.3b shows the amount o f peptide absorbed on silica nanoparticles. By
subtracting the original peptide concentration with the peptide concentration in the
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supernatant, the amount o f peptide adsorbed on the 20 mg silica nanoparticles alternated
with CMC was calculated as ca. 0.26 ± 0.01 mg for four peptide layer coatings and ca.
0.67 ± 0.01 mg for eight peptide layer coatings. The calculated amount o f peptide
adsorbed from QCM data showed ca. 0.40 ± 0.09 mg for four peptide layer coatings and
ca. 0.81 ± 0.18 mg for eight peptide layer coatings.
The kinetics o f the decomposition o f Phor21-pCG(ala)/CMC multilayers was first
elaborated using peptide coated glass slides. The results in Figure 4.4 show that the
release o f the peptide in 0.9 % NaCl USP injection solution was ca. 16 % after 17 hours.

Phor21~pCG(ala) Release Profile from Glass Slides Coated with 20
Layers of Peptide
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Figure 4.4: Release kinetics o f Phor21-|3CG(ala) from glass slides coated with 20 layers
o f peptide in 0.9 % NaCl USP injection media.

The release kinetics from peptide-silica nanoshells are shown in Figure 4.5 (see
page 55). The 0.9 % sodium chloride injection USP solution was used as the in vitro
release media, which kept the peptide active. The release media is biocompatible, non
pyrogenic, and can be used in future in vivo studies. The results showed that for 4 layer
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and 8 layer peptide coatings in alteration with CMC, the release is ca. 18 % for 28 hours.
The peptide release rates from the slides and nanoparticles followed an exponential
tendency [93].
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Figure 4.5: Release kinetics o f Phor21-pCG(ala) from peptide-silica nanoparticles with
four (open diamonds) and eight (closed boxes) peptide layer coatings with CMC as the
alternate layer. The error bars represent one standard deviation from the mean.

Discussion
The layer-by-layer assembly procedure resulted in nanoparticles that contained
increased amounts o f membrane disrupting peptide, Phor21-pCG(ala), which showed
sustained release over an extended time period.
The assembly o f Phor21-pCG(ala) with CMC and gelatin B on 450 nm Si02
nanoparticles was expected to follow the general scheme o f alternate adsorption of
oppositely charged linear polyelectrolytes [12, 13]. The 450 ± 30 nm diameter silica
cores were used for the drug shell assembly, but their diameter may be taken as small as
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100 nm without changing the technique (smaller diameter cores only need larger
centrifugation speeds at the sample separation stage). While this pattern was true for
silica nanoshells containing CMC, this was not the case when alternating adsorption was
conducted using Phor2l-(3CG(ala) with gelatin B. In this case, the surface charges did not
totally reverse when the peptide was adsorbed on the cores, except for the first peptide
layer. The surface charges o f the peptide layers remained negative (ca. -10 mV) during
the assembly and adsorption process. This may suggest weak electrostatic interactions
between the molecules o f the peptide and gelatin B [94, 95]. Combined with the QCM
results, it is still a useful indicator o f multilayer film growth on particles, even though
they alternated between higher and lower negative values [95].
The assembly results o f the peptide and polyelectrolytes on QCM resonators
confirmed the formation o f the multilayers corresponding to the planned wall
composition o f the silica nanoshells. The layer growths were linear on QCM resonators.
As to the peptide adsorption with gelatin B, one can see from Figure 4.3a (see
page 53) that the frequency decrease is sharper for peptide/gelatin B bi-layers than for
peptide/CMC bi-layers. The average thickness o f peptide layers was similar regardless o f
the polyelectrolyte used. The average thickness o f peptide layers was 0.72 ± 0.37 nm
(CMC) and 0.81 ± 0.18 nm (gelatin B) with estimated peptide amounts o f 0.09 - 0 .1 0 mg
Phor21-pCG(ala) per 20 mg o f silica shells per peptide layer. The substantial frequency
decrease was therefore due to the adsorption o f gelatin B rather than the peptide
adsorption.
Because the QCM experiments showed the peptide adsorption on planar
substrates with materials different from spherical silica nanoparticles, it can only
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indirectly estimate the amount o f peptide adsorbed in LbL multilayers, the amount of
peptide/CMC adsorption on silica nanoshells was further examined using the UV/Vis
method. By comparing the results obtained from UV/Vis and QCM, one can see that the
results obtained from QCM data was about 20 - 50 % higher than the results obtained
from UV/Vis data, and the UV/Vis results showed the exponential mass growth o f the
peptide adsorption, which is different from the linear growth o f the QCM results. The
reduced peptide adsorption could be due to the centrifugation and strong vortexing
applied to wash and resuspend the particles, and might explain the mass differences
between the QCM and UV/Vis results. The calculated amount o f peptide adsorbed from
QCM data showed 0.40 ± 0.09 mg for four peptide layer coatings and 0.81 ± 0.18 mg for
eight peptide layer coatings.
Usually, LbL assembled multilayers constructed from strong polyelectrolytes with
molecular weight larger than 10,000 are resistant to harsh environments [95]. The
stability o f layers composed o f smaller molecules and weak polyelectrolytes could be
affected significantly by surrounding conditions such as pH, ionic strength, enzymes, etc.,
and can be decomposed slowly. Hiller et al. reported that protamine assembled in
multilayers on colloidal particles could be exchanged and released up to 90 % [96].
Schuler et al. reported that hollow capsules based on deoxyribonucleic acid and
spermidine were decomposed after exposure to different concentrations o f sodium
chloride solutions [97], and Khopade et al. reported that the multilayers composed o f
dextran sulfate sodium salt and drug aminoglycoside tobramycin sulfate can be
decomposed in physiological buffer followed by mannitol and water [95].
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This data showed insignificant differences in the release kinetics o f peptides from
four layer compared to eight layer nanoshells. Both indicated a slow release o f Phor21pCG(ala) from LbL multilayers. This indicates the peptide release rate is not increased
with an increase in the number o f layers. An extrapolation o f the release curves predicted
that ca. 50 % release will be reached after 7 days or even longer.

Conclusion
The positively charged anticancer peptide, Phor21-pCG(ala), was assembled in
organized multilayer shells with sodium carboxymethyl cellulose (CMC) and gelatin B
on 450 nm diameter silica nanocores using the LbL technique, ^-potential experiments
confirmed the assembly o f nanoshells with drug molecules electrostatically bound into
the multilayers. The amount o f peptide included in the shell was estimated using both the
QCM and UV/Vis methods. The in vitro release kinetic results showed that Phor21pCG(ala) released from silica-peptide nanoshells was ca. 18 % in 28 hours.
Consequently, the encapsulation and sustained systemic release o f these peptides
could further improve treatment efficacy by avoiding toxicity o f systemic exposure at
high dosage and preserve the potency o f this highly sensitive drug through controlled and
sustained release. Layer-by-layer silica-peptide nanoshells may be used for sustained
release o f a membrane disrupting peptide drug to destroy primary tumors and metastases
in an effective and controlled fashion.
Although release o f peptide incorporated as part o f a polyelectrolyte multilayer
shell is novel, the technique is still dependent on physiological conditions such as pH. A
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different release technique, not dependent on physiological conditions, needs to be
developed. The use of magnetics may be the answer.
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CHAPTER 5

CONTROLLABLE PERMEABILITY USING
MAGNETIC NANOPARTICLES

Introduction
Another promising way to achieve permeability control is to embed magnetic
nanoparticles into capsule walls. The capsules might be modulated by an external
oscillating magnetic field to control the permeability when needed, thus control the
release of the substances in the capsules. Numerous studies have been conducted on
applying magnetic particles to treat human diseases, such as cancer [78-80, 98-102]. A
new concept for targeted as well as controlled release o f anticancer drugs, using magnetic
nanoparticles within a polymeric shell, has been recently proposed [103, 104]. The
magnetic fluid hyperthermia (MFH) method applies a high frequency alternating
magnetic field to heat superparamagnetic nanoparticles localized in a tumor to destroy
diseased cells without damaging healthy tissue [78-80], Magnetic particles, with
diameters ranging from nanometers to millimeters, were also studied to be embedded
inside alginate or liposome matrixes combined with drugs and tested for their controllable
drug release behavior using a low frequency external magnetic field [98, 99, 102].
Magnetic particles o f interest include magnetite, strontium ferrite, manganese ferrite, and
others [79, 101]. However, up to now, there is no study about embedding magnetic
nanoparticles into walls o f hollow capsules, thereby modulating the permeability and
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release behavior o f the capsules. In this work, superparamagnetic cobalt nanoparticles
coated with gold shells (Co@Au nanoparticles) were embedded into polyelectrolyte
capsules fabricated with layer-by-layer assembly o f poly(sodium 4-styrene sulfonate) and
poly(allylamine hydrochloride) (Figure 5.1). Application o f low frequency alternating
magnetic fields to such magnetic capsules resulted in an increase o f their wall
permeability; therefore, external magnetic fields may “switch on” unloading o f these
microcapsules.

Adding FITC
dextran

Co@Au nanoParticles adsorption

polyelectrolyte
layer adsorption

Dissolving
c o res

6,

\

-

/

Figure 5.1: Scheme o f the assembly and permeability test for microcapsules embedded
with Co@Au nanoparticles.

Experimental
Materials
Poly(sodium 4-styrene sulfonate) (PSS, MW 70,000 dal), poly(allylamine
hydrochloride) (PAH, MW 70,000 dal), and poly(diallyldimethylammonium chloride)
(PDDA, MW 1,000,000 dal) were used for LbL assembly. Fluorescein isothiocyanate
(FITC) and rhodamine B isothiocyanate (RBITC) were used to label dextran and PAH,
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respectively, following the procedure described in [26], which helps with capsule
visualization under confocal laser scanning microscopy (CLSM). FITC-dextran (MW
2,000,000 dal) was used for capsule permeability tests. Cobalt chloride (anhydrous,
beads, 99.99 %, packaged under argon in ampules), potassium tetrachloroaurate III
(99.999 %), tetrahydrofuran (THF, 99.9 %, inhibitor free, packaged under nitrogen),
lithium hydrotriethyl borate (superhydride) as 1 M solution in THF, dodecyldimethyl 3sulfopropyl ammonium hydroxide (SB 12), and ethanol (reagent grade, anhydrous, water
< 0.003 %) were used for the synthesis o f Co@Au nanoparticles. All the chemicals were
purchased from Sigma Aldrich and used without further treatments.

Co@,Au Nanoparticle Fabrication and Characterization
The Co@Au nanoparticles were fabricated using a chemical reduction method
[105]. The Co particles were fabricated using dodecyldimethyl 3-sulfopropyl ammonium
hydroxide (SB 12) as the surfactant to prevent agglomeration, and lithium hydrotriethyl
borate (LiBEtsH, superhydride) as the reducing agent. In order to prevent Co
nanoparticles from oxidization, a novel gold shell was formed around the Co particles by
a displacement method in THF (tetrahydrofuran) media based on the following reaction
[105-109]:
KAuCU + C0X-SB12 -» Co@Au-SB12 + KC1
In a typical procedure, the precursor cobalt nanoparticles were added to 50 mL
KAuCU (0.024 M) in THF solution under untrasonication and inert atmospheric
conditions. The initially brown colored solution changed to blue indicating that the gold
ions oxidized the cobalt surface atoms on the cobalt nanoparticles. The reaction was
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continued for an additional 1 hour and the core-shell nanoparticles were washed
thoroughly with THF and dried under vacuum. The resulted nanoparticles were
characterized using transmission electron microscopy (TEM, JEOL 2010) with an
accelerated voltage of 200 kV, and a zeta potential analyzer (Zeta Plus, Brookhaven
Instruments Corp.).
Co@Au nanoparticles were tested using a superconducting quantum interface
device magnetometer (SQUID, Quantum Design Inc., model MPMS 5S) to analyze the
magnetic properties o f the nanoparticles. The samples for magnetic measurements were
prepared in powder form in gelatin capsules. The temperature dependent magnetization
process was investigated using the zero field cooled (ZFC) and field cooled (FC) methods
[105]. ZFC was done by cooling the sample first to 4 K without a field; then
magnetization changes were recorded with the temperature increasing from 4 K to 300 K
with an applied field o f 100 Oe. FC was recorded immediately after ZFC by decreasing
the temperature from 300 K to 4 K with a constant field o f 100 Oe. Field dependent
magnetization was tested for two temperatures: 10 K and 300 K. In order to test the
oxidative stability o f the cobalt cores, both the zero field cooled and field cooled
methods, with an applied field o f 30 kOe at 10 K, were recorded.

Capsule Preparation
Hollow polyelectrolyte microcapsules were prepared using manganese carbonate
cores [110] with an average core diameter o f about 5.5 pm. First, 200 pL negatively

charged PSS solution and positively charged PAH solution, with concentrations of 2
mg/mL, were absorbed alternatingly on cores in 10 mL, 1 mg/mL MnCCf core aqueous
suspensions. For each polyelectrolyte layer, washing with DI water three times was
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carried out to remove excess polyelectrolytes after a 15 minute absorption period. Layer
forming continued until four bi-layers o f PSS and PAH were absorbed on the cores.
Then, after another layer o f PSS was adsorbed, 500 pL o f a 1.2 mg/mL Co@Au
nanoparticle solution was added into the MnC 0 3 core suspension. After a 30 minute
adsorption period, the cores with adsorbed Co@Au nanoparticles were washed three
times using DI water, the MnCCh cores with adsorbed Co@Au nanoparticles were
separated from the free (unabsorbed) nanoparticles in the solution by the precipitation
method. The free nanoparticles precipitate much slower than the cores with nanoparticles
adsorbed. An additional 2 - 6

PSS/PAH bi-layers were assembled to wrap up the

nanoparticles sequentially after the desired number o f Co@Au layers were coated on the
MnC 0 3 cores. The assembly o f layers can be confirmed by zeta potential changes o f the
core surface and quartz crystal microbalance resonance frequency changes (QCM, USISystems, Japan).
The manganese carbonate cores were dissolved using 0.1 M EDTA disodium salt
solution at a pH of about 4.5 for 3 - 4 hours [110]. After dissolving, the capsules obtained
were centrifuged and washed using DI water three to four times and stored in DI water.

Capsule Permeability Test
Hollow capsules were washed using pH 7.5, 0.02 M Tris buffer three times, and
then kept in the same buffer overnight to ensure the capsules were in a closed state [32,
33, 36], Confocal laser scanning microscopy (CLSM) was used to check the permeability
of capsules to macromolecules before and after applying alternating magnetic fields.
FITC-dextran, with a molecular weight o f 2,000,000 dal, was used as a fluorescence
indicator for diffusion tests. An alternating electromagnetic field, with frequencies
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ranging from 20 Hz to 2,000 Hz, and a magnetic field o f 0.1 T, was applied to oscillate
and disturb the Co@Au nanoparticles embedded inside the capsule walls. The magnetic
capsules were kept inside the alternating magnetic field for 5 - 3 0 minutes before
checking the permeability change o f their walls. The ratio o f fluorescence intensities
inside and outside o f the capsules was selected as a measurement for the capsule
permeability change. It is considered, in this dissertation, that the capsules are
impermeable if the fluorescenc intensity inside the capsules is 0.5 (7//0 = 0.5, where / is
the internal fluorescence intensity inside the capsules, and I0 is the external intensity
outside the capsules) less than that outside o f the capsules after adding fluorescence dye
for 15 minutes.

Capsule Characterization
Two kinds o f capsules were checked using scanning electron microscopy (SEM,
AMRAY 1830): capsules with and without embedded Co@Au nanoparticles. Samples
were prepared by drying capsules on 1 x 1 cm silicon wafers. After drying, platinum
sputtering was used to apply an ultrathin metal layer (~0.5 nm) to enhance the image
quality taken in the experiments.
Confocal laser scanning microscopy (CLSM) and atomic force microscopy
(AFM) were used to investigate the size, morphology, and structure o f hollow
microcapsules embedded with Co@Au nanoparticles, and capsule permeability changes
before and after applying an alternating m agnetic field. For microcapsule checking with

atomic force microscopy, the Q-ScopeTM 250 Quesant instrument with intermittentcontact mode was used. The samples were prepared by adding about 10 pL nanoparticle
suspensions on a 1.5 x 1.5 cm mica slide and dried for 24 hours before checking. In order
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to allow CLSM to check the capsules and their loading, the capsules were fabricated
using RBITC-labeled PAH, and fluorescent FITC-dextran (MW 2,000,000 dal) was used
as macromolecules for the permeability tests. Before applying an alternating magnetic
field, 20 pL capsule suspensions were mixed with 20 pL FITC-dextran solution (0.5
mg/mL, pH 7.5), and checked by CLSM for fluorescence intensity changes inside the
capsules every 5 minutes up to 1 hour. Subsequently, 50 pL capsule suspensions were
mixed with 50 pL FITC-dextran solution. The mixture was put in an alternating magnetic
field and the fluorescence intensity was checked every 5 minutes. The solution pH values
were kept at 7.5 all the time during the experiments. The CLSM used in this work is a
confocal laser scanning microscopy (Leica-SP2, Germany) with a 63x oil immersion
objective.

Results and Discussion
Co@,Au Nanoparticle Characterization
Figure 5.2 (see page 67) shows the UV/Vis spectrum o f Co@Au core-shell
nanoparticles in ethanol solution. The presence o f an absorption peak at 585 nm due to
the gold plasmon resonance is indicative o f the formation of a Au shell around the cobalt
nanoparticles. It was reported that the Co nanoparticles have no plasmon resonance peak
in the UV region [111-113]. A large red shift o f the plasmon absorption, when compared
with pure gold nanoparticles (-530 nm) [112], could be attributed to the presence o f a
cobalt core and also indicate that almost no free gold nanoparticles were formed in the
displacement reaction, which is consistent with the literature report on gold coated silver
nanoparticles [112]. Such a shift was previously noticed in the case o f gold coated y-
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Fe 2 C>3 core-shell nanoparticles, gold coated silver nanoparticles, and for a silver shell
around a silica core [112, 114, 115].
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Figure 5.2: UV/Vis spectrum o f Co@Au nanoparticles showing the Au absorbance peak
at 585 nm.
Figure 5.3 (see page 68) shows a TEM bright-fleld micrograph o f the Co@Au
core-shell nanoparticles. The nanoparticles were found to be nearly monodispersed with a
diameter o f 2.7 ± 0.5 nm (the diameter was calculated using Scion software from Scion
Corporation for counting more than 150 nanoparticles). The image contrast, which is
directly related to differences in the atomic number or projected specimen mass
thickness, has been used as a distinguishing criterion for the core-shell structure [116118]. The formation o f a more spherical shell, rather than other shapes, is due to its lower
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surface energy compared with other shapes. The gold shell thickness was also estimated
based on the weight percentage o f gold in the core-shell nanoparticles (Au wt % = 38.1,
determined from atomic absorption analysis) and the particle size from TEM, assuming
bulk density and standard spherical shape with symmetric structure.

Figure 5.3: Transmission electron microscopy (TEM) image o f Co@Au nanoparticles.
The particles are ~3 nm in diameter.

The blocking temperature (TB), determined at the maximum o f the zero field
cooled

(ZFC)

curve,

characterizes

the

transition

temperature

between

the

superparamagnetic state and the ferromagnetic state. At temperatures below the blocking
temperature, materials show ferromagnetic properties; whereas, at temperatures above the
blocking temperature, materials show paramagnetic properties, otherwise known as
superparamagnetism.

The

blocking

temperature

for

Co@Au

nanoparticles

is

approximately at room temperature (Figure 5.4, see page 69), unlike the blocking
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temperature for the precursor pure cobalt nanoparticles (125 K, superparamagnetic)
indicating that the core-shell nanoparticles are transitioning between ferromagnetic and
superparamagnetic states [105]. The coercivity of a hysteresis loop is the strength o f a
magnetic field needed to reduce the magnetization o f a ferromagnetic material to zero
after it has reached saturation [119]. A slight hysteresis observed at room temperature is a
confirmation o f the ferromagnetic nature o f the Co@Au nanoparticles. The reason for
this ferromagnetic nature o f the Co@Au nanoparticles will be discussed later.
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Figure 5.4: Temperature dependences o f the magnetic moment measured in zero field
cooled (ZFC) and field cooled (FC) modes for Co@Au nanoparticles (open squares) and
pure cobalt nanoparticles (closed squares). The blocking temperatures for Co@Au and
pure Co nanoparticles are approximately 300 K and 125 K, respectively.

Laver-bv-Layer Assem bly on OCM Electrodes and Microcores
Co@Au nanoparticles (DI water, pH -7 .0 ) were first checked using zeta potential
analysis, the obtained surface potential is +15 ± 5 mV for different nanoparticle batches.
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That indicates the surface charges o f the nanoparticles are positive, so negatively charged
PSS was selected to assemble altematingly with the Co@Au nanoparticles.
First, the assembly conditions on QCM resonators monitoring the process by the
weight addition on every deposition cycle was elaborated. The results are shown in
Figure 5.5. The plot shows a stable growth o f nanoparticle layers on the QCM resonator.
From the QCM frequency shift plot, one can see formation o f the multilayers
corresponding to the planned composition o f microcapsule walls: Four step precursor
layers followed by three bi-layers o f nanoparticles and PSS.

Assembly o f (PSS/Co@Au)j on a QCM Resonator

12 T
t o ■■

|
aft

Co@Au' 2.01 ± 0.13 nm
PSS:

1,51 ± 0,02 nm

I
Layers

Figure 5.5: Thickness changes by the alternating adsorption o f Co@Au nanoparticles
with PSS monitored using QCM.

Considering the Co density o f 8.7 g em ’3 and a particle packing coefficient o f ca.

74 %, the estimated monolayer thickness for Co@Au nanoparticles is ca. 4 - 6 nm. Here,
each nanoparticle in the monolayer (the nanoparticles were considered to form a
monolayer on the surface o f the resonator with a hexagonal close-packed (hep) structure)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

71

was considered as a sphere, which occupies 74 % o f a cubic structure as shown in the
following formulation:

6

3

3-\/3 22
-u c

3V3 22
a c

- ' ’V - J

3>/3

2* r
6>/2r

0.74,

(5.1)

where a (a = 2r) is the side length o f the hexagon, c (c = 3.21 r) is the height o f the
hexagon, and r is the radius o f the sphere. This is just an estimated value. This thickness
was obtained from the corresponding frequency shift using the Sauerbrey equation
supported with experimental scaling [13]. This value is consistent with the particle
diameter obtained from transmission electron microscopy (Figure 5.3, see page 68).
After elaboration of the assembly on planar QCM resonators, a similar
nanocomposite shell was assembled on manganese carbonate micro-cores: 4 bi-layers o f
PSS/PAH + 1 - 2 layers o f nanoparticles + 2 - 1 0 bi-layers o f PSS/PAH to cover the
nanoparticles. The layers were prepared in aqueous solution with suspended MnCCE
cores as mentioned in the Experiment Section. The final capsule wall composition was
(PSS/PAH)4 (PSS/Co@Au)i- 2 (PSS/PAH)2 -io- These capsules were used to evaluate their
permeability changes under an external alternating magnetic field in the next sections.
The influence of the capsule structure differences on the capsule permeability was also
investigated. Figure 5.6 (see page 72) shows the zeta potential changes for Co@Au layers
alternated with PSS on MnCCE micro-cores. First, there was regular alternation o f surface
potential with +45 ± 5 mV for PAFI and -30 ± 5 mV for PSS. After assembling one layer
of Co@Au nanoparticles, the surface charge became positive, +14 mV, and the next PSS
layer reversed it to negative, -40 mV. Then, again +8 mV for Co@Au and -42 mV for
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PSS. This is consistent to the general rule o f LbL assembly based on alternation of the
surface charge after every deposition step [12, 21-24],
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Figure 5.6: Zeta potential changes by alternating adsorption o f Co@Au with PSS on
MnC 0 3 cores.
After formation of the shells, the template cores were dissolved, and hollow
microcapsules were obtained, which were studied using confocal and atomic force
microscopy. Figure 5.7 (see page 73) shows the image o f the fluorescently labeled
magnetic capsules under CLSM; the average capsule diameter is about 5.5 pm. The
capsules were labeled with RBITC (rhodamine B isothiocyanate) dye. The fluorescence
emitting wavelength of the dye is -5 8 0 nm under CLSM. This allows us to clearly see the
capsule walls outlined in a red color. The capsule wall surface is rather rough with some
aggregates, which indicates the adsorption o f a larger than one monolayer amount o f
Co@Au nanoparticles.
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Figure 5.7: Confocal image o f RBITC-labeled (shown in red fluorescence) microcapsules
with one layer o f embedded Co@Au nanoparticles. The capsule structure is
(PSS/PAH)4 (PSS/Co@Au)i(PSS/PAH)6. The bottom-right inset shows the fluorescence
intensity of the RBITC in the cross-section of one capsule.

AFM analysis gave information o f the capsule wall thickness with and without
magnetic

nanoparticles:

capsules

with

wall

composition

of

(PSS/PAH)4 (PSS/Co@Au)i(PSS/PAH)6 and similar capsules without Co@Au were dried
and checked with AFM. The resulted average wall thickness o f the dried magnetic
capsules was ca. 500 nm, referring to the thickness o f the entire composition o f two
overlapped capsule walls, including the polyelectrolyte bi-layers. This can be compared
to the usual microcapsule thickness of 200 nm (overlapped capsule walls composed o f 10
polyelectrolyte bi-layers without embedded nanoparticles). Therefore, an average
thickness o f one Co@Au layer on cores may be estimated as ca. 150 nm. The aggregation
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o f magnetic nanoparticles was considered to be the main contribution o f such a large
thickness. It is reasonable that aggregation o f nanoparticles was seen in this case. Even
with charges on their surfaces, particles in the nano-scale have a tendency to aggregate
due to their large surface area, high interfacial energy, and hydrophobic effects.
SEM images in Figure 5.8 (see page 75) visually show the difference between
hollow capsules with and without embedded Co@Au nanoparticles. One can see a
structured surface o f magnetic microcapsules as compared with smoother and thinner
non-magnetic capsules (10 bi-layers o f PSS/PAH form the walls). The dried capsules
without Co@Au nanoparticles are rather thin, with smooth surfaces. Some wrinkles
indicate the folding of capsule walls during drying. Figure 5.8b (see page 75) shows the
morphology o f dried capsules embedded with one layer of Co@Au nanoparticles. The
average capsule diameter is about 6 pm with a thickness of ca. 0.5 pm; this is consistent
with the AFM results. The bulges on the capsules also indicate the aggregation of
Co@Au nanoparticles during LbL assembly. This is different from LbL assembly of
nanoparticles on a planar surface like QCM resonators where an overall growth step for
Co@Au nanoparticles was 5 ± 1 nm. It is assumed that drying o f the sample on QCM
resonators produce better layer organization due to capillary force ordering. These
aggregates increased the amount o f Co@Au adsorbed on the capsule walls and resulted in
a rougher topology o f the magnetic microcapsules.
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Figure 5.8: (a) SEM image of hollow capsules with (PSS/PAH)n, and (b) SEM image of
magnetic capsules with one layer of embedded Co@Au nanoparticles:
(PSS/PAH)4 (PSS/Co@Au)i(PSS/PAH)6 . Insets show zoomed image o f one capsule.

Magnetic Field Modification o f Capsule Permeability
It is assumed in this work that an alternating electromagnetic field influences the
Co@Au nanoparticles embedded in the capsule walls. Because the Co@Au particles are
superparamagnetic, the oscillating magnetic field will twist and shake the nanoparticles
with frequency corresponding to the frequency o f the applied field. This particle agitation
will disturb the structure o f the surrounding polyelectrolyte layers, which will result in
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layer structure distortion (some theoretical estimations o f corresponding processes are
given in the next section). This may result in loosening of the capsule walls and will
allow macromolecules to diffuse through the capsule walls. Thus, the permeability o f the
magnetic microcapsules may be “switched on” after applying an alternating magnetic
field with relatively low frequencies. It is believed that the “switching” rate may be
increased by finding the resonant frequency o f the capsule structure, and applying an
alternating magnetic field at this resonant frequency.
In these experiments, confocal microscopy was used to check the capsule
permeability changes under an alternating magnetic field. Before the experiment, the pH
value of the capsule suspension was adjusted to about 7.5 to ensure the capsule walls
were in a closed, non-permeable state [32, 33, 36], To check permeability, FITC-labeled
dextran (MW 2,000,000 dal, pH 7.5, 1 mg/mL) was added to the capsule suspension by
1:1 volume ratio. Figure 5.9a (see page 78) shows the capsule/FITC-dextran mixture
confocal image before applying an alternating magnetic field. The capsules with wall
structure o f (PSS/PAH)4 (PSS/Co@Au)i(PSS/PAH ) 6 were investigated here. The interior
o f the capsules was dark even after one hour o f mixing. From the fluorescence intensity
profile shown in the image, one can see no FITC-dextran diffused into the capsules after
one hour o f incubation; the average fluorescence intensity ratio inside and outside o f the
capsules was less than 0.2 (I/I0 < 0.2). Therefore, the permeability o f the capsules before
applying alternating magnetic fields was negligible, and FITC-dextran was blocked from
diffusion into the capsules. After applying an alternating electromagnetic field (0.1 T,
150 Hz) to the capsule/FITC-dextran mixture for 30 minutes, the capsules became
permeable (Figure 5.9b, see page 78). The image shows that the fluorescence intensity
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inside the capsules became the same as in bulk solution; the average fluorescence
intensity ratio inside and outside o f the capsules was about 1.1 (///„ ~ 1.1), which proved
there is a large enhancement o f FITC-dextran diffusion into the capsules. The
fluorescence intensity in the capsule walls was much higher because the capsule walls
were constructed from charged polyelectrolytes, which adsorbed more FITC-dextran than
the interior o f the capsules. By checking the capsules using CLSM, 99 % o f the capsules
analyzed were filled with FITC-dextran after applying an alternating magnetic field for
30 minutes. The same permeability experiments were run four separate times with similar
results. The experimental results supported the assumption that a low frequency
alternating magnetic field changes permeability o f magnetic capsules that allow the
macromolecules, which are usually excluded from the capsules, to penetrate into the
capsules. The permeability control mechanism is given in more detail in the Theoretical
Considerations section.
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Figure 5.9: Confocal laser scanning microscopy images o f magnetic capsules,
(PSS/PAH)4 (PSS/Co@Au)i(PSS/PAH) 6 , mixed with FITC-dextran (a) without applying
an alternating magnetic field, and (b) after applying an alternating magnetic field for 30
minutes, with corresponding optical density profiles.

Another part o f this work had to do with moving and focusing the magnetic
microcapsules with a permanent external magnetic field (-0.1 T). This was done first by
placing a permanent magnet near the Co@Au nanoparticles suspended in DI water. After
5 minutes, all the nanoparticles migrated to the magnet, and the bulk solution turned from
a murky color to transparent (Figure 5.10, see page 79). Then, similar experiments were
done with capsules embedded with Co@Au nanoparticles with analogous results. This
shows that the microcapsules embedded with Co@Au nanoparticles can be concentrated
using a permanent magnet. Therefore, any one approach, both "focusing" o f the capsules
to a specific location followed by "switching" them on to release their contents, are
suggested.
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Figure 5.10: (a) Co@Au nanoparticles suspended in DI water, (b) After application of a
permanent magnetic field, the magnetic nanoparticles migrate towards the magnet
leaving a clear solution of DI water behind.

Temperature and Frequency Effects
During the application o f an alternating magnetic field, a ~30 °C increase in
temperature for the sample was observed, as shown in Figure 5.11a (see page 80).
Therefore,

the two phenomena possibly

contributing to the

changing

o f the

polyelectrolyte wall permeability, heating of the sample and disturbing o f the capsule
walls, must be separated. From the literature [27, 30], it is known that heating provides an
opposite effect, decreasing wall permeability. Even so, an experiment was designed to
rule out the temperature influence on the capsule permeability. In this experiment,
magnetic capsules were mixed with FITC-dextran and heated to 50 °C for 30 minutes
(which were typical conditions when applying a magnetic field). The permeability was
checked (Figure 5.11b, see page 80), and the capsules were found not to be permeable;
the FITC-dextran remained excluded from the capsules even after 30 minutes and longer,
the average fluorescence intensity ratio inside and outside of the capsules (///„) was less
than 0.2. Thus, one can conclude that the temperature’s influence on the permeability of
capsules is negligible and even may oppose the magnetic effects, and the influence of
magnetic fields is the major factor contributing to the capsule permeability change.
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Figure 5.11: (a) Temperature increase tendency o f capsule suspensions when applying a
magnetic
field,
and
(b)
confocal
image
of
magnetic
capsules,
(PSS/PAH)4 (PSS/Co@Au)i(PSS/PAH) 6 , in a 1:1 mixture with FITC-dextran after
heating to 50 °C for 30 minutes.
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The influence o f frequencies of electromagnetic fields on the permeability of
capsule walls was also studied. The applied frequencies were ranged from 100 Hz to
1,000 Hz, while the strength o f the magnetic field was kept constant at 0.1 T. In
frequencies beyond 300 Hz, the diffusion o f FITC-dextran into capsules is negligible,
even after keeping the mixture for one hour in the magnetic field. For frequencies less
than 300 Hz, there is a tendency for faster diffusion of FITC-dextran with lower
frequencies. It seems that the increase o f frequency reduces agitation effects o f the
magnetic field on the Co@Au nanoparticles embedded in the capsule walls, which
reduces the permeability o f the magnetic capsules. This is consistent with the idea that
agitating magnetic forces have to correspond with mechanical properties o f the magnetic
particles and surrounding elasticity.

Optimization o f the Capsule Wall Composition
The increase in the number o f Co@Au nanoparticle layers significantly reduced
the permeability o f the capsules. After coating two layers of Co@Au nanoparticles, the
capsules were not permeable to FITC-dextran in any case; therefore, the use o f more than
one layer o f Co@Au nanoparticles is unsuitable for the experiments. The influence o f the
number of PSS and PAH layers on capsule permeability was also investigated. The
permeability change of the capsules was evaluated using the fluorescence intensity ratio
inside and outside the capsules after adding FITC-dextran into the capsule suspension as
the above section described. The blue line with diamond markers in Figure 5.12 (see page

82) shows the permeability change tendency with changes in the number of
polyelectrolyte bi-layers for capsules without embedded nanoparticles. The capsules with
less than 4 bi-layers are easily permeable to FITC-dextran (///„ > 0.9). The permeability is
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gradually reduced as the number o f bi-layers is increased, and totally impermeable to
FITC-dextran with more than 8 bi-layers (III0 < 0.1). The red line with square markers in
Figure 5.12 shows the permeability changes o f capsules with one layer o f embedded
Co@Au nanoparticles. The permeability o f the magnetic capsules is enhanced when
compared to the capsules without nanoparticles, but general curve behavior is the same. It
was also found that, in an alternating electromagnetic field, the magnetic capsules will
not be open for FITC-dextran if more than 10 polyelectrolyte bi-layers (PSS/PAH) are
assembled because o f increased electrostatic interactions.
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Figure 5.12: Influence o f polyelectrolyte bi-layer numbers on the permeability of
capsules with and without an embedded layer o f Co@Au nanoparticles at pH 7.5.

Theoretical Considerations
It is easy to show that ideal isolated hep (hexagonal-close packed) Co

nanoparticles, with diameter ~3 nm, should be superparamagnetic at room temperature
with blocking temperature TB ~ 4 K from the equation
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where K u = 4.1 x 105 J in 3 (anisotropy constant), V is the particle volume, and kB is the
Boltzman constant. Such nanoparticles should have a very low magnetic moment at room
temperature in reasonable magnetic fields. In reality, the situation is even worse because
it is difficult to expect perfect crystallinity for particles o f 3 nm in diameter. Moreover, in
our case, partial oxidation o f cobalt takes place. A typical shift o f the hysteresis loop
along the H -axis for nanoparticles brought down to 30 kOe due to unidirectional
anisotropy, which is a result o f the formation o f an oxide layer [120], was observed
(Figure 5.13, see page 84). The oxidation should also decrease the magnetic moment of
the nanoparticles. However, magnetic data obtained for dried, as-prepared Co@Au
nanoparticles show that they have slight ferromagnetic properties due to the small
hysteresis. The only possible explanation o f this fact is aggregation and coupling of the
Co@Au nanoparticles. Due to the magnetostatic interaction between nanoparticles,
aggregations became ferromagnetic. Correlation o f magnetic moments o f chaotically
oriented particles leads to a fairly narrow hysteresis loop at room temperature (Figure
5.13, see page 84). Thus, the resulting volume o f the aggregates should be at least a
hundred times the volume of the individual nanoparticles (i.e. a diameter o f the aggregate
would be at least 6 times larger than that o f the Co@Au nanoparticle).

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

84

0.2.

0 .0 -

-

0 . 1-

-0.2

3

£

0.0

-

4000-2000

0

2000 4000

CD

-

0. 1 -

-

0 .2 -

T =10 K, ZFC
T =10 K, FC
T =300 K

-40000

-20000

0

20000

40000

H (Oe)

Figure 5.13: Magnetic hysteresis curve for Co@Au nanoparticles. Inset shows zoomed
curve. The small hysteresis indicates slight ferromagnetic properties in the material.

Let us consider the action of alternating magnetic fields on polyion capsules with
embedded cobalt ferromagnetic nanoparticles. There are several mechanisms, which can
lead to formation stresses inside o f the shell. One such mechanism is the deformation o f
the capsule could lead to a decrease o f the viscous interaction due to a decreasing cross
sectional area. However, we cannot expect considerable gradients o f the magnetic field
(dH/Sx). The magnetic force,
S tt
F=M V ^-,
ox
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where M is the mean magnetization of the capsule and V is the volume, will be negligible.
Another mechanism is that the capsule in the magnetic field tried to stretch itself along
the field direction because it leads to a decrease o f magnetostatic energy,

E „ , = ^ ( n ' - N ^ M 2V,

(5.4)

where N 1 and N 1 are demagnetizing factors in the directions parallel and perpendicular
to the magnetic field, respectively. Taking into account real physical parameters o f the
capsules, one can show that the influence o f this should also be negligible [77, 121].
Besides, the increase o f the thickness o f the nanoparticle layer in this case would lead to
an increase of the influence o f the magnetic field.
Shape and magnetocrystalline anisotropy o f individual nanoparticles can affect
the permeability o f the capsules. The arising forces may be too low for substantial
deformation o f the capsules walls. This is not the case for aggregations o f nanoparticles.
Magnetostatic interactions inside the aggregations will lead to an appearance of fairly
large demagnetizing fields. In a magnetic field, they will try to align their easy-axis along
the direction o f the magnetic field. This results in the formation o f rather large stresses
inside the capsule walls. Such stresses can lead to an increase o f pore size in the capsule
walls, and in some cases even rupture the walls. It should be noted that all this
speculation is true for separated aggregates; otherwise, magnetostatic interactions
between the aggregates would suppress the demagnetizing factors o f the individual
aggregates [121].
As for the frequency behavior o f the permeability, the aggregates rotate, or
oscillate, under the action of the magnetic field with the elastic deformation of the
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capsule walls. At high frequencies, they will not follow the variation o f the magnetic field
and the deformation will be minimal, which leads to a decrease in permeability. This
corresponds to the forced oscillation of a pendulum at frequencies above the resonance
frequency. Unfortunately, it is impractical to calculate theoretically elastic forces for such
a complex system. Additionally, eigen-frequencies could be determined only by
experimentation.

Conclusion
The synthesized 3 nm diameter superparamagnetic Co@Au nanoparticles are
positively charged in DI water (~pH 7), and can be successfully absorbed on planar and
spherical surfaces in alternation with anionic polyelectrolyte layers. The 5.5 pm diameter
microcapsules, with nano-organized polymer walls embedded with Co@Au nanoparticle
layers, were successfully fabricated. They form a stable aqueous dispersion. Applying
external alternating electromagnetic fields o f 100 - 300 Hz and 0.1 T strength disturbed
the

capsule

wall

structures

and

drastically

increased

their

permeability

to

macromolecules. The embedded nanoparticles can be protected by the surrounding
polyelectrolyte layers from oxidation, which will keep them active for a longer time.
Capsules with one layer o f Co@Au nanoparticles and 10 polyelectrolyte bi-layers are
considered optimal for controlling permeability with alternating magnetic fields. This
work supports the hypothesis of using magnetic nanoparticles embedded in polyeletrolyte
capsules for controlled release o f substances, and offers a promising technology for
microcapsule “focusing” and “switchable” drug release in the biomedical field by using
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an external magnetic field to displace and open the capsules at designated places within
the body.
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CHAPTER 6

MAGNETICALLY ACTIVATED MICROCAPSULES
FOR THE CONTROLLED RELEASE OF
ENCAPSULATED DEXAM ETHASONE

Introduction
The controlled diffusion of dextran macromolecules through polyelectrolyte
layers has been established using superparamagnetic nanoparticles embedded in hollow
microcapsules [122], Here, dexamethasone, a hydrophobic drug, is micronized, and
biocompatible polyelectrolyte layers are assembled around the core for protection and
drug release control. Furthermore, a monolayer of superparamagnetic nanoparticles are
assembled between the polyelectrolyte layers in order to “focus” the capsules to specific
locations and to “switch on” the release o f the encapsulated drug by disturbing the
polyelectrolyte film with the use o f an external, alternating magnetic field.

Experimental
Materials
Protamine sulfate C (PS, MW 5,120 dal, positive) and gelatin B (GB, MW 20 25 kdal, negative) were obtained from Sigma Aldrich. Chondroitin sulfate sodium salt
(CS, negative) was purchased from Wako. Dexamethasone (Dexa, MW 392 dal,
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negative) was purchased from Spectrum. All of the materials above were used as
received. Gold coated cobalt (Co@Au, diameter ~3 nm, positive) was fabricated at the
Center for Advanced Microstructures and Devices, Louisiana State University, Baton
Rouge, Louisiana, USA [106],

Capsule Preparation
A 40 mg batch o f dexamethasone was added to 5 mL phosphate buffered saline
(PBS) and sonicated for five minutes in a bath. A 10 mL solution of protamine sulfate C
(5 mg/mL) was immediately added to the dexamethasone cores, and further sonication
was done for thirty minutes. The cores were then centrifuged at 10,000 RPM for 1
minute, the supemant was removed, and 1 mL fresh BPS buffer was added to the sample.
This was done three times to wash the sample. Subsequently, 1 mL chondroitin sulfate
sodium salt (5 mg/mL) was added to the samples and allowed to sit for 15 minutes to
allow self-assembly to take place. Another washing step took place to again clean the
sample. Alternating layers were assembled on the sample with intermediate washings
between

layers

to

form

the

following

layer

composition:

(PS/CS) i(PS/GB) i(Co@Au/GB), (PS/GB),.

Drug Release
The sample was separated into four batches. The four samples were analyzed
under different conditions: air and alternating magnetic fields of 150 Hz, 200 Hz, and 250
Hz (the samples in the magnetic field were run at a constant 0.1 T at their respective
frequencies). A variable voltage, variable frequency power source (Behlman, P I 351)
connected to a solenoid was used to generate the magnetic fields. A peristaltic pump (913
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Mity Flex Peristaltic Pump) was used to flow ice water around the solenoid to keep the
sample temperature at 11°C. The samples exposed to a magnetic field were placed in the
core of the solenoid, and the sample exposed only to air was kept in a tin can to keep any
external magnetic field from affecting the magnetic particles in the sample.
Each sample’s release was checked individual by allowing the sample to be
exposed to its respective environment for a specific time interval (~7 minutes). Then the
sample was centrifuged at 10,000 RPM for 30 seconds, and the supemant was extracted
and measured using UV/Vis (Agilent, 8543) at 243 nm to detect the amount of
dexamethasone in the supemant. A 1 mL solution of fresh PBS was then added to the
sample, and the sample was placed back in its respective environment. This process
repeated itself until no more dexamethasone remained in the core o f the microcapsules.

Results and Discussion
The ^-potential (Brookhaven Instruments Corporation Zeta Potential Analyzer) of
each layer assembled on dexamethasone cores was monitored to insure proper charge
reversal was taking place. The dexamethasone cores had a ^-potential o f -19.79 mV.
Upon addition o f protamine sulfate C, the surface charge revered to a ^-potential of
+12.00 mV. Again, adding chondroitin sulfate sodium salt reversed the surface charge to
give a ^-potential o f -37.75 mV. The surface charge continued to alternate as layers were
added (Figure 6.1, see page 91). The addition o f the Co@Au layer did not totally reverse
the surface charge o f the capsules; however, verification of the assembly was done by
viewing the capsules under confocal laser scanning microscopy (data not shown).
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Figure 6.1: Charge reversal of layers as they are assembled on dexamethasone cores with
the following composition: (PS/CS)i(PS/GB)i(Co@Au/GB)i(PS/GB)i.

The UV/Vis spectrum o f each data point was monitored at 243 nm, which is a
characteristic peak o f dexamethasone. Each data point is added to the previous data
points to give the total amount o f dexamethasone released over time. Figure 6.2 (see page
92) shows the release o f dexamethasone with (blue diamonds) and without (red squares)
an external alternating magnetic field. The magnetic field was applied at 200 Hz, 0.1 T.
After 30 minutes, the release o f dexamethasone under an applied magnetic field was
faster than for the samples without a magnetic field.
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Figure 6.2: Release o f dexamethasone with (blue triangles) and without (red squares) an
applied alternating magnetic field (200 Hz, 0.1 T). The dexamethasone release was
monitored using UV/Vis at 242 nm. The dexamethasone was encapsulated in
(PS/CS)i(PS/GB)i(Co@Au/GB)i(PS/GB)i microcapsules.

Conclusion
Layer-by-layer self-assembly was used to create a protective biocompatible
polymer film around the dexamethasone cores. The release o f dexamethasone from
polyelectrolyte capsules with an embedded layer o f superparamagnetic nanoparticles was
increased with the application o f an external alternating magnetic field. This method
offers a promising way o f delivering a controlled amount o f drugs to specific areas
without affecting the entire body.
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CHAPTER 7

CONCLUSION

In this dissertation, the use o f superparamagnetic nanoparticles was used to
enhance the release o f macromolecules from polyelectrolyte microcapsules fabricated via
layer-by-layer self-assembly; transforming the microcapsules into bio/nano robots
activated with external magnetic fields. This dissertation introduces and develops the
merger o f electrical engineering and pharmaceutics by incorporating magnetic
nanoparticles into drug release applications.
An anticancer polypeptide, Phor21-(3CG(ala), was used as one o f the layers in the
formation of polyelectrolyte shells around a silica core. Release o f the peptide was
accomplished through varying the pH of the release media. Although this technique was
found to be unique, the release mechanisms were still dependent on physiological
conditions.
Superparamagnetic nanoparticles were incorporated in the polyelectrolyte shells
to create a release mechanism that was not dependent on physiological conditions. Here,
permanent and alternating external magnetic fields were used to “focus” and “switch on”
the capsules, respectively. It was shown that the polyelectrolyte capsules, embedded with
magnetic nanoparticles, inhibited the diffusion o f FITC-dextran through the capsule walls
when no magnetic field was present; however, upon application o f an alternating
magnetic field, the capsules became permeable.
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The final step was to incorporate a drug with these capsules, to give enhanced
release characteristics. Polyelectrolyte multilayers, embedded with superparamagnetic
nanoparticles, were assembled around micronized dexamethasone cores. Because o f the
low molecular weight o f the dexamethasone used, dexamethasone was able to continually
diffuse through capsules walls; however, upon application o f an alternating magnetic
field, the release o f dexamethasone was increased.

Future Work
There are several things that can be done in future work to further build upon the
obtained results. Further studies need to be done to advance this development such as:
•

Use o f other types of superparamagnetic nanoparticles in the polymer matrix such
as Fe 2 0 3 /Fe 3 0 4 , which are less toxic than Co-based nanoparticles, Co@Cu,
Fe@Cu, and Fe@Ag should be studied to check the diffusion effects produced by
these nanoparticles;

•

Use of other encapsulated drugs for release studies such as furosemide,
nifedipine, paclitaxel, and tamoxifen in order to check the different diffusion
properties through the polyelectrolyte multilayers;

•

Modification of the polyelectrolyte layer composition so that there is reduced
diffusion of macromolecules with no magnetic field applied, and increased
diffusion o f macromolecules with an applied magnetic field; and

•

Creation o f a new setup which allows exposure o f magnetic fields to the release
chamber during diffusion and sample collection for 100 % exposure.
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